CN115819463A - Organic electroluminescent material and device - Google Patents

Organic electroluminescent material and device Download PDF

Info

Publication number
CN115819463A
CN115819463A CN202211124031.9A CN202211124031A CN115819463A CN 115819463 A CN115819463 A CN 115819463A CN 202211124031 A CN202211124031 A CN 202211124031A CN 115819463 A CN115819463 A CN 115819463A
Authority
CN
China
Prior art keywords
group
compound
independently
formula
deuterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211124031.9A
Other languages
Chinese (zh)
Inventor
陈小凡
格扎·西盖蒂
R·哈姆泽
尼古拉斯·J·汤普森
H·蔡
关伟业
R·尼拉拉普
C·J·斯坦顿
D·威廉姆斯
V·J·李
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universal Display Corp
Original Assignee
Universal Display Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/477,809 external-priority patent/US20220112232A1/en
Priority claimed from US17/482,695 external-priority patent/US20220115607A1/en
Priority claimed from US17/584,471 external-priority patent/US20220162246A1/en
Priority claimed from US17/842,117 external-priority patent/US20230115552A1/en
Priority claimed from US17/899,649 external-priority patent/US20230065887A1/en
Application filed by Universal Display Corp filed Critical Universal Display Corp
Publication of CN115819463A publication Critical patent/CN115819463A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Electroluminescent Light Sources (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The present application relates to organic electroluminescent materials and devices. Provides a formula I
Figure DDA0003847565530000011
The compound of (1). In the formula I, Z 1 、Z 2 And Z 3 One is N and the others are C; l is 1 And L 2 Each of which is independently selected from a direct bond and a linking group; r 1 、R 2 、R A 、R B 、R C 、R D And R E Comprises a group R having a structure selected from the group consisting of * : formula II, - - - -Q (R) 3 )(R 4 ) a (R 5 ) b (ii) a In the formula (III), the compound is shown in the formula,
Figure DDA0003847565530000012
and a compound of the formula IV,
Figure DDA0003847565530000013
each R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H Independently hydrogen or a general substituent, with the proviso that the radical R * Is not adamantyl. Formulations, OLEDs, and consumer products containing the compounds are also provided.

Description

Organic electroluminescent material and device
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application claims priority of 63/295,235, filed 2021, 12/30/month, according to 35u.s.c. § 119 (e). This application is also a continuation-in-part application of U.S. patent application No. 17/842,117, filed on 16/6/2022, and U.S. patent application No. 17/842,117 is a continuation-in-part application of U.S. patent application No. 17/477,809, filed on 17/9/17/2021, and U.S. patent application No. 17/477,809 claims priority from 35U.S. c. § 119 (e) claims U.S. provisional application No. 63/087,062, filed on 2/10/2020 and U.S. provisional application No. 63/193,755, filed on 27/5/2021. This application is also a continuation-in-part application of U.S. patent application Ser. No. 17/584,471, filed on 26/1/2022, and U.S. patent application Ser. No. 17/584,471, a continuation-in-part application of U.S. patent application Ser. No. 17/482,695, filed on 23/9/2021, and U.S. patent application Ser. No. 17/482,695 claims priority from 35U.S. C. § 119 (e) from 63/179,695, filed on 26/4/2021, and from 63/086,993, filed on 2/10/2020. The above referenced application is incorporated by reference herein in its entirety.
Technical Field
The present disclosure relates generally to organometallic compounds and formulations and various uses thereof, including as emitters in devices such as organic light emitting diodes and related electronic devices.
Background
Photovoltaic devices utilizing organic materials are becoming increasingly popular for a variety of reasons. Many of the materials used to make such devices are relatively inexpensive, and therefore organic photovoltaic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials (e.g., their flexibility) may make them more suitable for particular applications, such as fabrication on flexible substrates. Examples of organic optoelectronic devices include organic light emitting diodes/devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, organic materials may have performance advantages over conventional materials.
OLEDs utilize organic thin films that emit light when a voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for applications such as flat panel displays, lighting and backlighting.
One application of phosphorescent emissive molecules is full color displays. Industry standards for such displays require pixels adapted to emit a particular color, known as a "saturated" color. In particular, these standards require saturated red, green, and blue pixels. Alternatively, OLEDs can be designed to emit white light. In conventional liquid crystal displays, an absorptive filter is used to filter the emission from a white backlight to produce red, green, and blue emissions. The same technique can also be used for OLEDs. The white OLED may be a single emitting layer (EML) device or a stacked structure. Color can be measured using CIE coordinates well known in the art.
Disclosure of Invention
In one aspect, the disclosure provides a compound of formula I
Figure BDA0003847565510000021
In the formula (I), the compound is shown in the specification,
each of rings B, C and D is independently a 5-or 6-membered carbocyclic or heterocyclic ring;
Z 1 、Z 2 and Z 3 One is N and the others are C;
L 1 and L 2 Each of which is independently selected from the group consisting of: direct bond, BR, BRR ', NR, PR, P (O) R, O, S, se, C = O, C = S, C = Se, C = NR ', C = CR ' R ", S = O, SO 2 CR, CRR ', siRR ', geRR ', alkylene, cycloalkyl, aryl, cycloalkylene, arylene, heteroarylene, and combinations thereof;
R 1 、R 2 、R A 、R B 、R C 、R D and R E Comprises a group R having a structure selected from the group consisting of * : formula II, - - - -Q (R) 3 )(R 4 ) a (R 5 ) b (ii) a In the formula (III), the compound is shown in the formula,
Figure BDA0003847565510000022
and a compound of the formula IV,
Figure BDA0003847565510000023
R A 、R B 、R C 、R D 、R E 、R F 、R G 、R H each of which independently represents a single substitution to the maximum allowable number of substitutions or no substitution;
each R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H Independently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, seleno, and combinations thereof;
X 1 to X 20 Each of which is independently C or N;
Y A 、Y B and Y C Each of which is independently CRR 'or SiRR';
n is an integer between 1 and 4;
q is selected from C, si, N, O and B;
a and b are each independently 0 or 1;
when Q is C or Si, a + b =2;
when Q is N or B, a + B =1;
when Q is O, a + b =0;
when Q is Si, N, O or B, R 3 、R 4 Or R 5 At least one of the groups comprises deuterium;
when Q is C, R 3 、R 4 And R 5 Independently selected from the group consisting of: alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, and combinations thereof, which may be fully or partially deuterated, and at least one of the following four conditions is true:
(i)R 1 and R 2 Are not hydrogen, and the radical R * Comprising at least five carbon atoms, and,
(ii)R 1 and R 2 Is hydrogen, and the radical R * Containing at least ten carbon atoms, or
(iii)R 3 And R 4 Joined to form a ring, and R 5 In addition to the hydrogen, the aromatic ring is,
(iv)R * containing five or more carbon atoms, and R 3 、R 4 And R 5 At least one of which comprises deuterium;
when R is * Is formula IV, at least one of the following two conditions is true:
(a) At least one R H Is a substituent other than hydrogen or deuterium, and at least one R H Is deuterium;
(b)X 12 to X 16 Is N, and at least one R H Is deuterium;
any two of R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H May be joined or fused to form a ring; and is
Any two of R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H May be joined or fused to form a ring, provided thatThe group R * Is not adamantyl.
In another aspect, the present disclosure provides a formulation comprising a compound of formula I as described herein.
In yet another aspect, the present disclosure provides an OLED having an organic layer comprising a compound of formula I as described herein.
In yet another aspect, the present disclosure provides a consumer product comprising an OLED having an organic layer comprising a compound of formula I as described herein.
Drawings
Fig. 1 shows an organic light emitting device.
Fig. 2 shows an inverted organic light emitting device without a separate electron transport layer.
Detailed Description
A. Term(s) for
Unless otherwise specified, the following terms as used herein are defined as follows:
as used herein, the term "organic" includes polymeric materials and small molecule organic materials that may be used to fabricate organic optoelectronic devices. "Small molecule" refers to any organic material that is not a polymer, and "small molecules" may actually be quite large. In some cases, the small molecule may include a repeat unit. For example, the use of long chain alkyl groups as substituents does not remove a molecule from the "small molecule" class. Small molecules can also be incorporated into polymers, for example as pendant groups on the polymer backbone or as part of the backbone. Small molecules can also serve as the core moiety of a dendrimer, which consists of a series of chemical shells built on the core moiety. The core moiety of the dendrimer may be a fluorescent or phosphorescent small molecule emitter. Dendrimers can be "small molecules," and all dendrimers currently used in the OLED art are considered small molecules.
As used herein, "top" means furthest from the substrate, and "bottom" means closest to the substrate. Where a first layer is described as being "disposed over" a second layer, the first layer is disposed farther from the substrate. Other layers may be present between the first and second layers, unless it is specified that the first layer is "in contact with" the second layer. For example, a cathode may be described as "disposed over" an anode even though various organic layers are present between the cathode and the anode.
As used herein, "solution processable" means capable of being dissolved, dispersed or transported in and/or deposited from a liquid medium in the form of a solution or suspension.
A ligand may be referred to as "photoactive" when it is believed that the ligand contributes directly to the photoactive properties of the emissive material. A ligand may be referred to as "ancillary" when it is believed that the ligand does not contribute to the photoactive properties of the emissive material, but the ancillary ligand may alter the properties of the photoactive ligand.
As used herein, and as will be generally understood by those skilled in the art, if the first energy level is closer to the vacuum energy level, the first "Highest Occupied Molecular Orbital" (HOMO) or "Lowest Unoccupied Molecular Orbital" (LUMO) energy level is "greater than" or "higher than" the second HOMO or LUMO energy level. Since Ionization Potential (IP) is measured as negative energy relative to vacuum level, a higher HOMO level corresponds to an IP with a smaller absolute value (less negative IP). Similarly, a higher LUMO energy level corresponds to an Electron Affinity (EA) with a smaller absolute value (a less negative EA). On a conventional energy level diagram with vacuum levels at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. The "higher" HOMO or LUMO energy level appears closer to the top of this figure than the "lower" HOMO or LUMO energy level.
As used herein, and as will be generally understood by those skilled in the art, a first work function is "greater than" or "higher than" a second work function if the first work function has a higher absolute value. Since the work function is typically measured as negative relative to the vacuum level, this means that the "higher" work function is more negative (more negative). On a conventional energy level diagram with vacuum level at the top, the "higher" work function is illustrated as being farther from the vacuum level in the downward direction. Thus, the definitions of HOMO and LUMO energy levels follow a different rule than work functions.
The terms "halo," "halogen," and "halo" are used interchangeably and refer to fluorine, chlorine, bromine, and iodine.
The term "acyl" refers to a substituted carbonyl group (C (O) -R s )。
The term "ester" refers to a substituted oxycarbonyl group (-O-C (O) -R) s or-C (O) -O-R s ) A group.
The term "ether" means-OR s A group.
The terms "thio" or "thioether" are used interchangeably and refer to-SR s A group.
The term "seleno" refers to-SeR s A group.
The term "sulfinyl" refers to-S (O) -R s A group.
The term "sulfonyl" refers to-SO 2 -R s A group.
The term "phosphino" refers to-P (R) s ) 3 Group, wherein each R s May be the same or different.
The term "silyl" refers to-Si (R) s ) 3 Group, wherein each R s May be the same or different.
The term "germyl" refers to-Ge (R) s ) 3 Group, wherein each R s May be the same or different.
The term "boron group" means-B (R) s ) 2 Group or Lewis adduct thereof (R) -B (R) s ) 3 Group, wherein R s May be the same or different.
In each of the above, R s May be hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, and combinations thereof. Preferred R s Selected from the group consisting of: alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.
The term "alkyl" refers to and includes straight and branched chain alkyl groups. Preferred alkyl groups are those containing one to fifteen carbon atoms and include methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1-dimethylpropyl, 1, 2-dimethylpropyl, 2-dimethylpropyl, and the like. In addition, the alkyl group may be optionally substituted.
The term "cycloalkyl" refers to and includes monocyclic, polycyclic and spiroalkyl groups. Preferred cycloalkyl groups are those containing 3 to 12 ring carbon atoms and include cyclopropyl, cyclopentyl, cyclohexyl, bicyclo [3.1.1] heptyl, spiro [4.5] decyl, spiro [5.5] undecyl, adamantyl, and the like. In addition, the cycloalkyl group may be optionally substituted.
The term "heteroalkyl" or "heterocycloalkyl" refers to an alkyl or cycloalkyl group, respectively, having at least one carbon atom replaced with a heteroatom. Optionally, the at least one heteroatom is selected from O, S, N, P, B, si and Se, preferably O, S or N. In addition, heteroalkyl or heterocycloalkyl groups may be optionally substituted.
The term "alkenyl" refers to and includes straight and branched chain alkenyl groups. An alkenyl group is essentially an alkyl group that includes at least one carbon-carbon double bond in the alkyl chain. Cycloalkenyl is essentially cycloalkyl that includes at least one carbon-carbon double bond in the cycloalkyl ring. The term "heteroalkenyl" as used herein refers to an alkenyl group having at least one carbon atom replaced with a heteroatom. Optionally, the at least one heteroatom is selected from O, S, N, P, B, si and Se, preferably O, S or N. Preferred alkenyl, cycloalkenyl or heteroalkenyl groups are those containing from two to fifteen carbon atoms. In addition, the alkenyl, cycloalkenyl or heteroalkenyl groups may be optionally substituted.
The term "alkynyl" refers to and includes straight and branched chain alkynyl groups. Alkynyl is essentially an alkyl group comprising at least one carbon-carbon triple bond in the alkyl chain. Preferred alkynyl groups are those containing from two to fifteen carbon atoms. In addition, alkynyl groups may be optionally substituted.
The terms "aralkyl" or "arylalkyl" are used interchangeably and refer to an alkyl group substituted with an aryl group. In addition, the aralkyl group may be optionally substituted.
The term "heterocyclyl" refers to and includes both aromatic and non-aromatic cyclic groups containing at least one heteroatom. Optionally, the at least one heteroatom is selected from O, S, N, P, B, si and Se, preferably O, S or N. Aromatic heterocyclic groups may be used interchangeably with heteroaryl groups. Preferred non-aromatic heterocyclic groups are heterocyclic groups containing 3 to 7 ring atoms including at least one heteroatom and include cyclic amines such as morpholinyl, piperidinyl, pyrrolidinyl and the like, and cyclic ethers/thioethers such as tetrahydrofuran, tetrahydropyran, tetrahydrothiophene and the like. In addition, the heterocyclic group may be optionally substituted.
The term "aryl" refers to and includes monocyclic aromatic hydrocarbon radicals and polycyclic aromatic ring systems. Polycyclic rings can have two or more rings in which two carbons are common to two adjoining rings (the rings are "fused"), wherein at least one of the rings is an aromatic hydrocarbyl, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryls, heterocyclics, and/or heteroaryls. Preferred aryl groups are those containing from six to thirty carbon atoms, preferably from six to twenty carbon atoms, more preferably from six to twelve carbon atoms. Especially preferred are aryl groups having six carbons, ten carbons, or twelve carbons. Suitable aryl groups include phenyl, biphenyl, terphenyl, triphenylene, and the like Tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene,
Figure BDA0003847565510000061
Perylene and azulene, preferably phenyl, biphenyl, terphenyl, triphenylene, fluorene and naphthalene. In addition, the aryl group may be optionally substituted.
The term "heteroaryl" refers to and includes monocyclic aromatic groups and polycyclic aromatic ring systems that include at least one heteroatom. Heteroatoms include, but are not limited to, O, S, N, P, B, si, and Se. In many cases, O, S or N are preferred heteroatoms. Monocyclic heteroaromatic systems are preferably monocyclic with 5 or 6 ring atoms, and rings may have one to six heteroatoms. A heteropolycyclic system can have two or more rings in which two atoms are common to two adjoining rings (the rings are "fused"), wherein at least one of the rings is heteroaryl, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryls, heterocycles and/or heteroaryls. The heterocyclic aromatic ring system may have one to six heteroatoms per ring of the polycyclic aromatic ring system. Preferred heteroaryl groups are those containing from three to thirty carbon atoms, preferably from three to twenty carbon atoms, more preferably from three to twelve carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolobipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indolizine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furobipyridine, benzothienopyridine, thienobipyridine, benzothienopyridine, benzonaphthopyridine, selenophene bipyridine, and selenophenodipyridine, preferably dibenzothiophene, dibenzofuran, dibenzothiophene, carbazole, indolocarbazole, imidazole, pyridine, triazine, benzimidazole, 1, 2-azaborine, 1, 3-azaborine, 1, 4-azaborane, 1, 4-azaalkyne, and their analogs. In addition, the heteroaryl group may be optionally substituted.
Of the aryl and heteroaryl groups listed above, triphenylene, naphthalene, anthracene, dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, pyrazine, pyrimidine, triazine, and benzimidazole are of particular interest, as well as their respective aza-analogs.
The terms alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aralkyl, heterocyclyl, aryl, and heteroaryl as used herein are independently unsubstituted or independently substituted with one or more general substituents.
In many cases, typical substituents are selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, seleno, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In some cases, preferred general substituents are selected from the group consisting of: deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, thio, and combinations thereof.
In some cases, more preferred general substituents are selected from the group consisting of: deuterium, fluoro, alkyl, cycloalkyl, alkoxy, aryloxy, amino, silyl, aryl, heteroaryl, thio, and combinations thereof.
In other cases, most preferred general substituents are selected from the group consisting of: deuterium, fluoro, alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.
The terms "substituted" and "substitution" mean that a substituent other than H is bonded to the relevant position, e.g., carbon or nitrogen. For example, when R is 1 When representing a single substitution, then one R 1 Must not be H (i.e., substituted). Similarly, when R is 1 When representing disubstituted, then two R 1 Must not be H. Similarly, when R is 1 When represents zero or no substitution, R 1 For example, it may be hydrogen of available valency for the ring atoms, such as the carbon atom of benzene and the nitrogen atom of pyrrole, or it may be hydrogen of only zero for ring atoms having fully saturated valency, such as the nitrogen atom of pyridine. The maximum number of substitutions possible in a ring structure will depend on the total number of available valences in the ring atoms.
As used herein, "a combination thereof" means that one or more members of the applicable list are combined to form a known or chemically stable arrangement that one of ordinary skill in the art can envision from the applicable list. For example, alkyl and deuterium can be combined to form a partially or fully deuterated alkyl; halogen and alkyl may combine to form haloalkyl substituents; and halogen, alkyl, and aryl groups may be combined to form haloaralkyl groups. In one example, the term substituted includes combinations of two to four of the listed groups. In another example, the term substitution includes a combination of two to three groups. In yet another example, the term substitution includes a combination of two groups. Preferred combinations of substituents are those containing up to fifty atoms other than hydrogen or deuterium, or those containing up to forty atoms other than hydrogen or deuterium, or those containing up to thirty atoms other than hydrogen or deuterium. In many cases, a preferred combination of substituents will include up to twenty atoms that are not hydrogen or deuterium.
The term "aza" in the fragment described herein, i.e., aza-dibenzofuran, aza-dibenzothiophene, etc., means that one or more of the C-H groups in the corresponding aromatic ring can be replaced by a nitrogen atom, for example and without any limitation, azatriphenylene encompasses dibenzo [ f, H ] quinoxaline and dibenzo [ f, H ] quinoline. Other nitrogen analogs of the aza-derivatives described above can be readily envisioned by one of ordinary skill in the art, and all such analogs are intended to be encompassed by the term as set forth herein.
As used herein, "deuterium" refers to an isotope of hydrogen. Deuterated compounds can be readily prepared using methods known in the art. For example, U.S. patent No. 8,557,400, patent publication No. WO 2006/095951, and U.S. patent application publication No. US 2011/0037057 (which are incorporated herein by reference in their entirety) describe the preparation of deuterium substituted organometallic complexes. Further reference is made to \37154, ming (Ming Yan) et al, tetrahedron (Tetrahedron) 2015,71,1425-30 and aztret (Atzrodt) et al, german applied chemistry (angelw.chem.int.ed.) (review) 2007,46,7744-65, which are incorporated in their entirety by reference, describe efficient routes for deuteration of the methylene hydrogens in benzylamines and for replacement of aromatic ring hydrogens with deuterium, respectively.
It is understood that when a molecular fragment is described as a substituent or otherwise attached to another moiety, its name can be written as if it were a fragment (e.g., phenyl, phenylene, naphthyl, dibenzofuranyl) or as if it were an entire molecule (e.g., benzene, naphthalene, dibenzofuran). As used herein, these different named substituents or the manner of linking the fragments are considered equivalent.
In some cases, a pair of adjacent substituents may optionally join or be fused to form a ring. Preferred rings are five-, six-or seven-membered carbocyclic or heterocyclic rings, including both cases where a portion of the ring formed by the pair of substituents is saturated and where a portion of the ring formed by the pair of substituents is unsaturated. As used herein, "adjacent" means that the two substituents involved can be on the same ring next to each other, or on two adjacent rings having two nearest available substitutable positions (e.g., the 2, 2' positions in biphenyl or the 1, 8 positions in naphthalene), so long as they can form a stable fused ring system.
B. Compounds of the present disclosure
In one aspect, the present disclosure provides a compound of formula I
Figure BDA0003847565510000091
In the formula I, the compound is shown in the specification,
each of rings B, C and D is independently a 5-or 6-membered carbocyclic or heterocyclic ring;
Z 1 、Z 2 and Z 3 One is N and the others are C;
L 1 and L 2 Each of which is independently selected from the group consisting of: direct bond, BR, BRR ', NR, PR, P (O) R, O, S, se, C = O, C = S, C = Se, C = NR ', C = CR ' R ", S = O, SO 2 CR, CRR ', siRR ', geRR ', alkylene, cycloalkyl, aryl, cycloalkylene, arylene, heteroarylene, and combinations thereof;
R 1 、R 2 、R A 、R B 、R C 、R D and R E Comprises a group R having a structure selected from the group consisting of * : formula II, - - - -Q (R) 3 )(R 4 ) a (R 5 ) b (ii) a In the formula (III), the compound is shown in the formula,
Figure BDA0003847565510000092
and a compound of the formula IV,
Figure BDA0003847565510000093
R A 、R B 、R C 、R D 、R E 、R F 、R G 、R H each independently represents mono-to maximum permissible substitution or no substitution;
each R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H Independently hydrogen or a substituent selected from the group consisting of the general substituents defined herein;
X 1 to X 20 Each of which is independently C or N;
Y A 、Y B and Y C Each of which is independently CRR 'or SiRR';
n is an integer between 1 and 4;
q is selected from C, si, N, O and B;
a and b are each independently 0 or 1;
when Q is C or Si, a + b =2;
when Q is N or B, a + B =1;
when Q is O, a + b =0;
when Q is Si, N, O or B, R 3 、R 4 Or R 5 At least one of the groups comprises deuterium;
when Q is C, R 3 、R 4 And R 5 Independently selected from the group consisting of: alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, and combinations thereof, which may be fully or partially deuterated, and at least one of the following four conditions is true:
(i)R 1 and R 2 Are not hydrogen, and the radical R * Comprising at least five carbon atoms, and,
(ii)R 1 and R 2 Is hydrogen, and the radical R * Containing at least ten carbon atoms, or
(iii)R 3 And R 4 Joined to form a ring, and R 5 In addition to the hydrogen, the aromatic ring is,
(iv)R * containing five or more carbon atoms, and R 3 、R 4 And R 5 At least one of which comprises deuterium;
when R is * Is formula IV, at least one of the following two conditions is true:
(a) At least one R H Is a substituent other than hydrogen or deuterium, and at least one R H Is deuterium;
(b)X 12 to X 16 Is N, and at least one R H Is deuterium;
any two of R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H May be joined or fused to form a ring; and is
Any two of R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H May be joined or fused to form a ring, with the proviso that the group R * Is not adamantyl.
In some embodiments, each of rings B, C, and D is independently a 5-or 6-membered aryl or heteroaryl ring.
In some embodiments, each of rings B, C, and D is independently a 6-membered aryl or heteroaryl ring.
In some embodiments, each of rings B, C, and D is independently selected from the group consisting of: benzene, pyridine, pyrimidine, pyridazine, pyrazine, imidazole, pyrazole, pyrrole, oxazole, furan, thiophene and thiazole.
In some embodiments, each R, R', R 1 、R 2 、R A 、R B 、R C 、R D 、R E 、R F And R G Independently hydrogen or a substituent selected from the group consisting of the preferred general substituents defined herein. In some embodiments, each R, R', R 1 、R 2 、R A 、R B 、R C 、R D 、R E 、R F And R G Independently hydrogen or a substituent selected from the group consisting of the more preferred general substituents defined herein. In some embodiments, each R, R', R 1 、R 2 、R A 、R B 、R C 、R D 、R E 、R F And R G Independently hydrogen or a substituent selected from the group consisting of the most preferred general substituents defined herein.
In some embodiments, the compound has the structure of formula IA
Figure BDA0003847565510000111
Wherein X 4 ' to X 15 Each of' is independently C or N.
In some embodiments, Z 1 Is N. In some embodiments, Z 2 Is N. In some embodiments, Z 3 Is N.
In some embodiments, L 1 Is a direct bond. In some embodiments, L 1 Selected from the group consisting of O, S and Se. In some embodiments, L 1 Selected from the group consisting of BR, NR, PR, and CR. In some embodiments, L 1 Selected from the group consisting of BRR ', CRR', siRR ', and GeRR'. In some embodiments, L 1 Selected from the group consisting of C = X, S = O and SO 2 A group of combinations thereof.
In some embodiments, L 2 Is a direct bond. In some embodiments, L 2 Selected from the group consisting of O, S and Se. In some embodiments, L 2 Selected from the group consisting of BR, NR, PR, and CR. In some embodiments, L 2 Selected from the group consisting of BRR ', CRR', siRR 'and GeRR'. In some embodiments, L 2 Selected from the group consisting of C = X, S = O and SO 2 A group of combinations thereof.
In some embodiments, L 1 Selected from the group consisting of O, S and Se, and L 2 Selected from the group consisting of BR and NR. In some embodiments, L 1 = O and L 2 =NR。
In some embodiments, R 1 Or R 2 At least one of which comprises a group R *
In some embodiments, R 1 And R 2 Each of which contains a group R *
In some embodiments, at least one R A Containing the group R *
In some embodiments, at least one R B Containing the group R *
In some embodiments, at least one R C Containing the group R *
In some embodiments, at least one R D Containing the group R *
In some embodiments, at least one R E Containing the group R *
In some embodiments, at least one R F Containing the group R *
In some embodiments, at least one R G Containing the group R *
In some embodiments, R 1 、R 2 Is connected to X 6 ' R of D Or at least one of R of the NR moiety comprises a group R *
In some embodiments, two R A Joined or fused together to form a ring. In some embodiments, two R B Joined or fused together to form a ring. In some embodiments, two R C Joined or fused together to form a ring. In some embodiments, two R D Joined or fused together to form a ring. In some embodiments, two R E Joined or fused together to form a ring. In some embodiments, two R F Joined or condensedTogether to form a ring. In some embodiments, two R G Joined or fused together to form a ring.
In some embodiments, at least one group R * Has the structure of formula II.
In which R is * In some embodiments having the structure of formula II, (i) R 1 And R 2 Are not hydrogen, and the radical R * Comprising at least five carbon atoms. In which R is * In some embodiments having the structure of formula II, (II) R 1 And R 2 Is hydrogen, and the radical R * Containing at least ten carbon atoms. In which R is * In some embodiments having the structure of formula II, (iii) R 3 And R 4 Joined to form a ring, and R 5 Is not hydrogen.
In some embodiments, the compound has a structure selected from the group consisting of:
Figure BDA0003847565510000121
Figure BDA0003847565510000131
Figure BDA0003847565510000141
in which R is * In some embodiments having the structure of formula II, the group R * Selected from the group consisting of the structures of list 1 below:
Figure BDA0003847565510000151
Figure BDA0003847565510000161
Figure BDA0003847565510000171
Figure BDA0003847565510000181
Figure BDA0003847565510000191
Figure BDA0003847565510000201
Figure BDA0003847565510000211
wherein R is a1 And R a2 Independently selected from the group consisting of:
Figure BDA0003847565510000212
Figure BDA0003847565510000213
Figure BDA0003847565510000221
and is
Wherein R is l 、R m 、R n And R o Each of which is independently selected from the group consisting of the structures of list 4 as defined herein.
In some embodiments, at least one group R * Having the structure of formula III.
In which R is * In some embodiments having the structure of formula III, n =1. In which R is * In some embodiments having the structure of formula III, n =2. In which R is * In some embodiments having the structure of formula III, n =3. In which R is * In some embodiments having the structure of formula III, n =4.
In some embodiments of formula I, X 1 To X 20 Each of which is C. In some embodiments of formula I, X 1 To X 20 Is N.
In some embodiments, X 1 To X 3 Each of which is C.
In some embodiments of formula IA, X 4 ' to X 7 Each of' is C.
In some embodiments of formula IA, X 8 ' to X 10 Each of' is C.
In some embodiments of formula IA, X 11 ' to X 13 Each of' is C.
In some embodiments of formula IA, X 14 ' to X 15 Each of' is C.
In some embodiments of formula IA, X 16 ' to X 19 Each of' is C.
In some embodiments, X 1 To X 3 Is N. In some embodiments, X 1 To X 3 Is N.
In some embodiments, X 4 ' to X 7 At least one of is N. In some embodiments, X 4 ' to X 7 Exactly one of is N.
In some embodiments, X 8 ' to X 10 At least one of is N. In some embodiments, X 8 ' to X 10 Exactly one of' is N.
In some embodiments, X 11 ' to X 13 At least one of is N. In some embodiments, X 11 ' to X 13 Exactly one of' is N.
In some embodiments, X 14 ' to X 15 At least one of is N. In some embodiments, X 14 ' to X 15 Exactly one of is N.
In some embodiments, X 16 ' to X 19 At least one of is N. In some embodiments, X 16 ' to X 19 Exactly one of is N.
In some embodiments, the compound is selected from the group consisting of compounds having the formula Pt (L) A' ) (Ly) a group consisting of compounds of (Ly):
Figure BDA0003847565510000231
wherein L is A' Selected from the group consisting of the structures shown in the following list 2:
Figure BDA0003847565510000232
wherein L is y Selected from the group consisting of the structures shown in table 3 below:
Figure BDA0003847565510000233
Figure BDA0003847565510000241
Figure BDA0003847565510000251
wherein Ph represents a phenyl group;
wherein each R 1 、R 2 、R A 、R B 、R E 、R F 、R Q '、R R '、R S '、R T '、R X 、R X ' and R Y Independently selected from the group consisting of the structures in the following list 4:
Figure BDA0003847565510000252
Figure BDA0003847565510000261
Figure BDA0003847565510000271
Figure BDA0003847565510000281
Figure BDA0003847565510000291
Figure BDA0003847565510000301
Figure BDA0003847565510000311
Figure BDA0003847565510000321
Figure BDA0003847565510000331
Figure BDA0003847565510000341
Figure BDA0003847565510000351
Figure BDA0003847565510000361
Figure BDA0003847565510000371
Figure BDA0003847565510000381
Figure BDA0003847565510000391
Figure BDA0003847565510000401
Figure BDA0003847565510000411
Figure BDA0003847565510000421
Figure BDA0003847565510000431
Figure BDA0003847565510000441
Figure BDA0003847565510000442
wherein R is a1 And R a2 Independently selected from the group consisting of:
Figure BDA0003847565510000443
Figure BDA0003847565510000444
Figure BDA0003847565510000451
in some embodiments, the compound is selected from the group consisting of compounds having the formula Pt (L) A' )(L y ) The group consisting of:
wherein L is A' Selected from the group consisting of the structures shown in the following list 5:
Figure BDA0003847565510000452
Figure BDA0003847565510000461
wherein L is y Selected from the group consisting of the structures shown in the following list 6:
Figure BDA0003847565510000462
Figure BDA0003847565510000471
Figure BDA0003847565510000481
Figure BDA0003847565510000491
wherein each of q, r, s, t, u, v, w, z, a ', b', c ', d', e ', t', v ', w' is independently an integer from 1 to 658;
wherein R1 through R658 have the following structures defined in list 7 below:
Figure BDA0003847565510000492
Figure BDA0003847565510000493
Figure BDA0003847565510000501
Figure BDA0003847565510000511
Figure BDA0003847565510000521
Figure BDA0003847565510000531
Figure BDA0003847565510000541
Figure BDA0003847565510000551
Figure BDA0003847565510000561
Figure BDA0003847565510000571
and R209 to R658 are defined as follows:
Figure BDA0003847565510000572
Figure BDA0003847565510000581
wherein A1 to a25 have the structures as defined in the following list 8:
Figure BDA0003847565510000582
Figure BDA0003847565510000583
in some embodiments, the compound is selected from the group consisting of the structures of table 9 below:
Figure BDA0003847565510000584
Figure BDA0003847565510000591
Figure BDA0003847565510000601
Figure BDA0003847565510000611
Figure BDA0003847565510000621
Figure BDA0003847565510000631
Figure BDA0003847565510000641
Figure BDA0003847565510000651
Figure BDA0003847565510000661
Figure BDA0003847565510000671
Figure BDA0003847565510000681
Figure BDA0003847565510000691
Figure BDA0003847565510000701
Figure BDA0003847565510000711
Figure BDA0003847565510000721
Figure BDA0003847565510000731
Figure BDA0003847565510000741
Figure BDA0003847565510000751
Figure BDA0003847565510000761
Figure BDA0003847565510000771
Figure BDA0003847565510000781
Figure BDA0003847565510000791
Figure BDA0003847565510000801
Figure BDA0003847565510000811
in some embodiments, a compound having a structure of formula I described herein can be at least 30% deuterated, at least 40% deuterated, at least 50% deuterated, at least 60% deuterated, at least 70% deuterated, at least 80% deuterated, at least 90% deuterated, at least 95% deuterated, at least 99% deuterated, or 100% deuterated. As used herein, percent deuteration has its ordinary meaning and includes the percentage of possible hydrogen atoms (e.g., positions that are hydrogen, deuterium, or halogen) that are replaced by deuterium atoms.
C. OLEDs and devices of the present disclosure
In another aspect, the present disclosure also provides an OLED device comprising a first organic layer comprising a compound as disclosed in the above compounds section of the present disclosure.
In some embodiments, an OLED comprises: an anode; a cathode; and an organic layer disposed between the anode and the cathode, wherein the organic layer comprises a compound of formula I as defined herein.
In some embodiments, the organic layer may be an emissive layer and the compound as described herein may be an emissive dopant or a non-emissive dopant.
In some embodiments, the organic layer may further comprise a host, wherein the host comprises a triphenylene comprising a benzo-fused thiophene or a benzo-fused furan, wherein any substituent in the host is a non-fused substituent independently selected from the group consisting of: c n H 2n+1 、OC n H 2n+1 、OAr 1 、N(C n H 2n+1 ) 2 、N(Ar 1 )(Ar 2 )、CH=CH-C n H 2n+1 、C≡CC n H 2n+1 、Ar 1 、Ar 1 -Ar 2 、C n H 2n -Ar 1 Or no substituent, wherein n is 1 to 10; and wherein Ar 1 And Ar 2 Independently selected from the group consisting of: benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof.
In some embodiments, the organic layer may further comprise a host, wherein the host comprises at least one chemical group selected from the group consisting of: triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5 λ 2-benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole, 5, 9-dioxa-13 b-boronaphtho [3,2,1-de ] anthracene, triazine, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-5 λ 2-benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole, and aza- (5, 9-dioxa-13 b-boronaphtho [3,2,1-de ] anthracene).
In some embodiments, the subject may be selected from the group of subjects consisting of:
Figure BDA0003847565510000821
Figure BDA0003847565510000831
Figure BDA0003847565510000832
and combinations thereof.
In some embodiments, the organic layer may further comprise a host, wherein the host comprises a metal complex.
In some embodiments, a compound as described herein may be a sensitizer; wherein the device may further comprise a receptor; and wherein the receptor may be selected from the group consisting of: fluorescent emitters, delayed fluorescent emitters, and combinations thereof.
In yet another aspect, the OLEDs of the present disclosure can further comprise an emissive region comprising a compound as disclosed in the above compounds section of the present disclosure.
In some embodiments, the emissive region may comprise a compound of formula I as defined herein.
In some embodiments, at least one of the anode, cathode, or new layer disposed over the organic emissive layer serves as an enhancement layer. The enhancement layer includes a plasmonic material exhibiting surface plasmon resonance that non-radiatively couples to the emitter material and transfers excited state energy from the emitter material to a non-radiative mode of surface plasmon polaritons. The enhancement layer is disposed at a distance from the organic emissive layer that does not exceed a threshold distance, wherein the emitter material has a total nonradiative decay rate constant and a total radiative decay rate constant due to the presence of the enhancement layer, and the threshold distance is a location where the total nonradiative decay rate constant is equal to the total radiative decay rate constant. In some embodiments, the OLED further comprises an outcoupling layer. In some embodiments, the outcoupling layer is disposed on the enhancement layer on the opposite side of the organic emission layer. In some embodiments, the outcoupling layer is disposed on the opposite side of the emission layer from the enhancement layer, but is still capable of outcoupling energy from surface plasmon modes of the enhancement layer. The outcoupling layer scatters energy from surface plasmon polaritons. In some embodiments, this energy is scattered into free space as photons. In other embodiments, energy is scattered from a surface plasmon mode of the device into other modes, such as, but not limited to, an organic waveguide mode, a substrate mode, or another waveguide mode. If the energy is scattered into a non-free space mode of the OLED, other outcoupling schemes can be incorporated to extract the energy into free space. In some embodiments, one or more intervening layers may be disposed between the enhancement layer and the outcoupling layer. Examples of intervening layers may be dielectric materials, including organic, inorganic, perovskite, oxide, and may include stacks and/or mixtures of these materials.
The enhancement layer alters the effective characteristics of the medium in which the emitter material resides, thereby causing any or all of: reduced emissivity, linear change in emission, angular change in emission intensity, change in emitter material stability, change in OLED efficiency, and reduced roll-off efficiency of the OLED device. Placing the enhancement layer on the cathode side, the anode side, or both sides results in an OLED device that takes advantage of any of the effects described above. In addition to the specific functional layers mentioned herein and illustrated in the various OLED examples shown in the figures, the OLEDs of the present disclosure may also include any other functional layers that are common in OLEDs.
The enhancement layer may comprise a plasmonic material, an optically active metamaterial or a hyperbolic metamaterial. As used herein, a plasmonic material is a material in which the real part of the dielectric constant crosses zero in the visible or ultraviolet region of the electromagnetic spectrum. In some embodiments, the plasmonic material comprises at least one metal. In such embodiments, the metal may include at least one of: ag. Al, au, ir, pt, ni, cu, W, ta, fe, cr, mg, ga, rh, ti, ru, pd, in, bi, ca, alloys or mixtures of these materials, and stacks of these materials. In general, a metamaterial is a medium composed of different materials, wherein the medium as a whole acts differently than the sum of its material parts. Specifically, we define an optically active metamaterial as a material having both negative permittivity and negative permeability. On the other hand, hyperbolic metamaterials are anisotropic media in which the permittivity or permeability has different signs for different spatial directions. Optically active and hyperbolic metamaterials are strictly distinguished from many other photonic structures, such as Distributed Bragg reflectors ("DBRs"), because the medium should appear uniform in the propagation direction on the length scale of the optical wavelength. Using terminology understood by those skilled in the art: the dielectric constant of the metamaterial in the propagation direction can be described by an effective medium approximation. Plasmonic and metamaterial materials provide a means for controlling light propagation that can enhance OLED performance in a variety of ways.
In some embodiments, the reinforcement layer is provided as a planar layer. In other embodiments, the enhancement layer has features of wavelength size arranged periodically, quasi-periodically, or randomly, or features of sub-wavelength size arranged periodically, quasi-periodically, or randomly. In some embodiments, the wavelength-sized features and the sub-wavelength-sized features have sharp edges.
In some embodiments, the outcoupling layer has features of wavelength size that are arranged periodically, quasi-periodically, or randomly, or features of sub-wavelength size that are arranged periodically, quasi-periodically, or randomly. In some embodiments, the outcoupling layer may be composed of a plurality of nanoparticles, and in other embodiments, the outcoupling layer is composed of a plurality of nanoparticles disposed over the material. In these embodiments, the out-coupling may be adjusted by at least one of the following: varying a size of the plurality of nanoparticles, varying a shape of the plurality of nanoparticles, varying a material of the plurality of nanoparticles, adjusting a thickness of the material, varying a refractive index of the material or an additional layer disposed on the plurality of nanoparticles, varying a thickness of the enhancement layer, and/or varying a material of the enhancement layer. The plurality of nanoparticles of the device may be formed from at least one of: a metal, a dielectric material, a semiconductor material, a metal alloy, a mixture of dielectric materials, a stack or a laminate of one or more materials, and/or a core of one type of material and coated with a shell of another type of material. In some embodiments, the outcoupling layer is composed of at least metal nanoparticles, wherein the metal is selected from the group consisting of: ag. Al, au, ir, pt, ni, cu, W, ta, fe, cr, mg, ga, rh, ti, ru, pd, in, bi, ca, alloys or mixtures of these materials, and stacks of these materials. The plurality of nanoparticles may have an additional layer disposed thereon. In some embodiments, an outcoupling layer may be used to adjust the polarization of the emission. Varying the size and periodicity of the outcoupling layer can select the type of polarization that is preferentially outcoupled to air. In some embodiments, the outcoupling layer also serves as an electrode of the device.
In yet another aspect, the present disclosure also provides a consumer product comprising an Organic Light Emitting Device (OLED) having an anode; a cathode; and an organic layer disposed between the anode and the cathode, wherein the organic layer can comprise a compound as disclosed in the above compounds section of the present disclosure.
In some embodiments, the consumer product comprises an OLED having an anode; a cathode; and an organic layer disposed between the anode and the cathode, wherein the organic layer can comprise a compound of formula I as described herein.
In some embodiments, the consumer product may be one of the following: a flat panel display, a computer monitor, a medical monitor, a television, a billboard, a light for interior or exterior lighting and/or signaling, a heads-up display, a fully or partially transparent display, a flexible display, a laser printer, a telephone, a cellular telephone, a tablet, a phablet, a Personal Digital Assistant (PDA), a wearable device, a laptop computer, a digital camera, a video camera, a viewfinder, a microdisplay at a diagonal of less than 2 inches, a 3-D display, a virtual reality or augmented reality display, a vehicle, a video wall containing multiple displays tiled together, a theater or stadium screen, a phototherapy device, and a sign.
Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When current is applied, the anode injects holes and the cathode injects electrons into the organic layer. The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and a hole are located on the same molecule, an "exciton," which is a localized electron-hole pair with an excited energy state, is formed. When the exciton relaxes by a light emission mechanism, light is emitted. In some cases, the exciton may be localized on an excimer (eximer) or an exciplex. Non-radiative mechanisms (such as thermal relaxation) may also occur, but are generally considered undesirable.
Several OLED materials and configurations are described in U.S. patent nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.
The initial OLEDs used emissive molecules that emit light from a singlet state ("fluorescence"), as disclosed, for example, in U.S. patent No. 4,769,292, which is incorporated by reference in its entirety. Fluorescence emission typically occurs in a time frame of less than 10 nanoseconds.
More recently, OLEDs having emissive materials that emit light from the triplet state ("phosphorescence") have been demonstrated. Baldo (Baldo) et al, "high efficiency Phosphorescent Emission from Organic Electroluminescent Devices," Nature, 395, 151-154,1998 ("Baldo-I"); and baldo et al, "Very high-efficiency green organic light-emitting devices based on electrophosphorescence (Very high-efficiency green organic light-emitting devices-based on electrophosphorescence)", applied physical promo (appl. Phys. Lett.), volume 75, stages 3,4-6 (1999) ("baldo-II"), which are incorporated by reference in their entirety. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704, columns 5-6, which is incorporated by reference.
Fig. 1 shows an organic light emitting device 100. The figures are not necessarily to scale. Device 100 can include substrate 110, anode 115, hole injection layer 120, hole transport layer 125, electron blocking layer 130, emissive layer 135, hole blocking layer 140, electron transport layer 145, electron injection layer 150, protective layer 155, cathode 160, and blocking layer 170. Cathode 160 is a composite cathode having a first conductive layer 162 and a second conductive layer 164. The device 100 may be fabricated by depositing the layers in sequence. The nature and function of these various layers and example materials are described in more detail in U.S. Pat. No. 7,279,704, columns 6-10, which is incorporated by reference.
More of each of these layers can be obtainedExamples are given. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is doped with F at a molar ratio of 50 4 m-MTDATA of TCNQ, as disclosed in U.S. patent application publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of luminescent and host materials are disclosed in U.S. Pat. No. 6,303,238 to Thompson et al, which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entirety, disclose examples of cathodes comprising composite cathodes having a thin layer of a metal (e.g., mg: ag) with an overlying transparent, conductive, sputter-deposited ITO layer. The theory and use of barrier layers is described in more detail in U.S. patent No. 6,097,147 and U.S. patent application publication No. 2003/0230980, which are incorporated by reference in their entirety. Examples of injection layers are provided in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of protective layers can be found in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety.
Fig. 2 shows an inverted OLED 200. The device includes a substrate 210, a cathode 215, an emissive layer 220, a hole transport layer 225, and an anode 230. The device 200 may be fabricated by depositing the layers in sequence. Because the most common OLED configuration has a cathode disposed above an anode, and device 200 has a cathode 215 disposed below an anode 230, device 200 may be referred to as an "inverted" OLED. Materials similar to those described with respect to device 100 may be used in corresponding layers of device 200. Fig. 2 provides one example of how some layers may be omitted from the structure of device 100.
The simple layered structure illustrated in fig. 1 and 2 is provided by way of non-limiting example, and it is to be understood that embodiments of the present disclosure may be used in conjunction with various other structures. The specific materials and structures described are exemplary in nature, and other materials and structures may be used. Functional OLEDs may be obtained by combining the various layers described in different ways, or the layers may be omitted entirely based on design, performance, and cost factors. Other layers not specifically described may also be included. Materials other than those specifically described may be used. Although many of the examples provided herein describe the various layers as comprising a single material, it is understood that combinations of materials may be used, such as mixtures of hosts and dopants, or more generally, mixtures. Further, the layer may have various sub-layers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200, hole transport layer 225 transports holes and injects holes into emissive layer 220, and may be described as a hole transport layer or a hole injection layer. In one embodiment, an OLED may be described as having an "organic layer" disposed between a cathode and an anode. This organic layer may comprise a single layer, or may further comprise multiple layers of different organic materials as described, for example, with respect to fig. 1 and 2.
Structures and materials not specifically described may also be used, such as OLEDs (PLEDs) comprising polymeric materials, such as disclosed in U.S. patent No. 5,247,190 to frand et al, which is incorporated by reference in its entirety. By way of further example, OLEDs having a single organic layer may be used. The OLEDs may be stacked, for example, as described in U.S. patent No. 5,707,745 to Forrest et al, which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in fig. 1 and 2. For example, the substrate may include an angled reflective surface to improve out-coupling (out-coupling), such as a mesa structure as described in U.S. Pat. No. 6,091,195 to Foster et al, and/or a pit structure as described in U.S. Pat. No. 5,834,893 to Boolean (Bulovic) et al, which are incorporated by reference in their entirety.
Any of the layers of the various embodiments may be deposited by any suitable method, unless otherwise specified. For organic layers, preferred methods include thermal evaporation, ink jetting (as described in U.S. Pat. nos. 6,013,982 and 6,087,196, which are incorporated by reference in their entirety), organic vapor deposition (OVPD) (as described in U.S. Pat. No. 6,337,102 to folster et al, which is incorporated by reference in their entirety), and deposition by organic vapor jet printing (OVJP, also known as Organic Vapor Jet Deposition (OVJD)) (as described in U.S. Pat. No. 7,431,968, which is incorporated by reference in its entirety). Other suitable deposition methods include spin coating and other solution-based processes. The solution-based process is preferably carried out in a nitrogen or inert atmosphere. For other layers, a preferred method includes thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding (as described in U.S. Pat. nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entirety), and patterning associated with some of the deposition methods such as inkjet and Organic Vapor Jet Printing (OVJP). Other methods may also be used. The material to be deposited may be modified to suit the particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3 to 20 carbons is a preferred range. A material with an asymmetric structure may have better solution processibility than a material with a symmetric structure because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.
Devices fabricated according to embodiments of the present disclosure may further optionally include a barrier layer. One use of barrier layers is to protect the electrodes and organic layers from damage from exposure to hazardous substances in the environment including moisture, vapor, and/or gas. The barrier layer may be deposited on, under or beside the substrate, electrode, or on any other part of the device, including the edges. The barrier layer may comprise a single layer or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase and compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate an inorganic compound or an organic compound or both. Preferred barrier layers comprise a mixture of polymeric and non-polymeric materials as described in U.S. patent No. 7,968,146, PCT patent application nos. PCT/US2007/023098 and PCT/US2009/042829, which are incorporated herein by reference in their entirety. To be considered a "mixture," the aforementioned polymeric and non-polymeric materials that make up the barrier layer should be deposited under the same reaction conditions and/or simultaneously. The weight ratio of polymeric material to non-polymeric material may be in the range of 95. The polymeric material and the non-polymeric material may be produced from the same precursor material. In one example, the mixture of polymeric material and non-polymeric material consists essentially of polymeric silicon and inorganic silicon.
Devices manufactured according to embodiments of the present disclosure may be incorporated into a wide variety of electronic component modules (or units), which may be incorporated into a wide variety of electronic products or intermediate components. Examples of such electronic products or intermediate components include display screens, lighting devices (e.g., discrete light source devices or lighting panels), etc., which may be utilized by end-user product manufacturers. The electronics module may optionally include drive electronics and/or a power source. Devices manufactured in accordance with embodiments of the present disclosure may be incorporated into a wide variety of consumer products having one or more electronic component modules (or units) incorporated therein. A consumer product comprising an OLED comprising a compound of the present disclosure in an organic layer in the OLED is disclosed. The consumer product shall include any kind of product comprising one or more light sources and/or one or more of some type of visual display. Some examples of such consumer products include flat panel displays, curved displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior lighting and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, rollable displays, foldable displays, stretchable displays, laser printers, telephones, cellular phones, tablets, phablets, personal Digital Assistants (PDAs), wearable devices, laptop computers, digital cameras, video cameras, viewfinders, microdisplays (displays less than 2 inches diagonal), 3-D displays, virtual reality or augmented reality displays, vehicles, video walls containing multiple displays tiled together, theater or stadium screens, phototherapy devices, and signs. Various control mechanisms may be used to control devices made in accordance with the present disclosure, including passive matrices and active matrices. Many of the devices are intended to be used in a temperature range that is comfortable for humans, such as 18 ℃ to 30 ℃, and more preferably at room temperature (20-25 ℃), but can be used outside this temperature range (e.g., -40 ℃ to +80 ℃).
More details regarding OLEDs and the definitions described above can be found in U.S. patent No. 7,279,704, which is incorporated herein by reference in its entirety.
The materials and structures described herein may be applied to devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices such as organic transistors may employ the materials and structures.
In some embodiments, the OLED has one or more features selected from the group consisting of: flexible, rollable, foldable, stretchable, and bendable. In some embodiments, the OLED is transparent or translucent. In some embodiments, the OLED further comprises a layer comprising carbon nanotubes.
In some embodiments, the OLED further comprises a layer comprising a delayed fluorescence emitter. In some embodiments, the OLED comprises an RGB pixel arrangement or a white plus color filter pixel arrangement. In some embodiments, the OLED is a mobile device, a handheld device, or a wearable device. In some embodiments, the OLED is a display panel having a diagonal of less than 10 inches or an area of less than 50 square inches. In some embodiments, the OLED is a display panel having a diagonal of at least 10 inches or an area of at least 50 square inches. In some embodiments, the OLED is a lighting panel.
In some embodiments, the compound may be an emissive dopant. In some embodiments, the compounds may produce emission via phosphorescence, fluorescence, thermally activated delayed fluorescence (i.e., TADF, also known as E-type delayed fluorescence, see, e.g., U.S. application No. 15/700,352, which is incorporated herein by reference in its entirety), triplet-triplet annihilation, or a combination of these processes. In some embodiments, the emissive dopant may be a racemic mixture, or may be enriched in one enantiomer. In some embodiments, the compounds may be homoleptic (each ligand is the same). In some embodiments, the compounds may be compounded (at least one ligand being different from the others). In some embodiments, when there is more than one ligand that coordinates to the metal, the ligands may all be the same. In some other embodiments, at least one ligand is different from the other ligands. In some embodiments, each ligand may be different from each other. This is also true in embodiments where the ligand that coordinates to the metal can be linked to other ligands that coordinate to the metal to form a tridentate, tetradentate, pentadentate, or hexadentate ligand. Thus, where the coordinating ligands are linked together, in some embodiments all of the ligands may be the same, and in some other embodiments at least one of the linked ligands may be different from the other ligand(s).
In some embodiments, the compounds may be used as phosphorous photosensitizers in OLEDs, where one or more layers in the OLED contain an acceptor in the form of one or more fluorescent and/or delayed fluorescence emitters. In some embodiments, the compounds may be used as a component of an exciplex to be used as a sensitizer. As a phosphosensitizer, the compound must be capable of energy transfer to the acceptor and the acceptor will emit or further transfer energy to the final emitter. The receptor concentration may range from 0.001% to 100%. The acceptor may be in the same layer as the phosphorous sensitizer or in one or more different layers. In some embodiments, the receptor is a TADF emitter. In some embodiments, the acceptor is a fluorescent emitter. In some embodiments, the emission may be produced by any or all of the sensitizer, the receptor, and the final emitter.
According to another aspect, a formulation comprising a compound described herein is also disclosed.
The OLEDs disclosed herein can be incorporated into one or more of consumer products, electronic component modules, and lighting panels. The organic layer may be an emissive layer, and the compound may be an emissive dopant in some embodiments, while the compound may be a non-emissive dopant in other embodiments.
In yet another aspect of the present invention, a formulation comprising the novel compound disclosed herein is described. The formulation may include one or more of the components disclosed herein selected from the group consisting of: a solvent, a host, a hole injection material, a hole transport material, an electron blocking material, a hole blocking material, and an electron transport material.
The present disclosure encompasses any chemical structure comprising the novel compounds of the present disclosure or monovalent or multivalent variants thereof. In other words, the compounds of the present invention or monovalent or multivalent variants thereof may be part of a larger chemical structure. Such chemical structures may be selected from the group consisting of: monomers, polymers, macromolecules and supramolecules (also known as supramolecules). As used herein, "monovalent variant of a compound" refers to a moiety that is the same as a compound but one hydrogen has been removed and replaced with a bond to the rest of the chemical structure. As used herein, "multivalent variants of a compound" refers to moieties that are the same as a compound but where more than one hydrogen has been removed and replaced with one or more bonds to the rest of the chemical structure. In the case of supramolecules, the compounds of the invention may also be incorporated into supramolecular complexes without covalent bonds.
D. Combinations of the compounds of the present disclosure with other materials
Materials described herein as suitable for use in a particular layer in an organic light emitting device can be used in combination with a variety of other materials present in the device. For example, the emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, barrier layers, implant layers, electrodes, and other layers that may be present. The materials described or referenced below are non-limiting examples of materials that can be used in combination with the compounds disclosed herein, and one of ordinary skill in the art can readily review the literature to identify other materials that can be used in combination.
a) Conductive dopant:
the charge transport layer may be doped with a conductivity dopant to substantially change its charge carrier density, which in turn will change its conductivity. The conductivity is increased by the generation of charge carriers in the host material and, depending on the type of dopant, a change in the Fermi level of the semiconductor can also be achieved. The hole transport layer may be doped with a p-type conductivity dopant and an n-type conductivity dopant is used in the electron transport layer.
Non-limiting examples of conductivity dopants that can be used in OLEDs in combination with the materials disclosed herein, along with references disclosing those materials, are exemplified below: EP01617493, EP01968131, EP2020694, EP2684932, US20050139810, US20070160905, US20090167167, US2010288362, WO06081780, WO2009003455, WO2009008277, WO2009011327, WO2014009310, US2007252140, US2015060804, US20150123047 and US2012146012.
Figure BDA0003847565510000911
Figure BDA0003847565510000921
b)HIL/HTL:
The hole injection/transport material used in the present disclosure is not particularly limited, and any compound may be used as long as the compound is generally used as a hole injection/transport material. Examples of materials include (but are not limited to): phthalocyanine or porphyrin derivatives; an aromatic amine derivative; indolocarbazole derivatives; a fluorocarbon-containing polymer; a polymer having a conductive dopant; conductive polymers such as PEDOT/PSS; self-assembled monomers derived from compounds such as phosphonic acids and silane derivativesA body; metal oxide derivatives, e.g. MoO x (ii) a p-type semiconducting organic compounds, such as 1,4,5,8,9, 12-hexaazatriphenylhexacyano-nitrile; a metal complex; and a crosslinkable compound.
Examples of aromatic amine derivatives for use in HILs or HTLs include, but are not limited to, the following general structures:
Figure BDA0003847565510000922
Ar 1 to Ar 9 Each of which is selected from: a group consisting of aromatic hydrocarbon cyclic compounds such as: benzene, biphenyl, terphenyl, triphenylene, naphthalene, anthracene, benzene, phenanthrene, fluorene, pyrene,
Figure BDA0003847565510000923
Perylene and azulene; a group consisting of aromatic heterocyclic compounds such as: dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolobipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indolizine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furobipyridine, benzothienopyridine, thienobipyridine, benzoselenenopyridine, and selenenopyridine; and a group consisting of 2 to 10 cyclic structural units which are the same type or different types of groups selected from aromatic hydrocarbon ring groups and aromatic heterocyclic groups and are bonded to each other directly or via at least one of an oxygen atom, a nitrogen atom, a sulfur atom, a silicon atom, a phosphorus atom, a boron atom, a chain structural unit and an aliphatic ring group. Each Ar may be unsubstituted or may be substituted by a substituent selected from the group consisting ofGeneration: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In one aspect, ar 1 To Ar 9 Independently selected from the group consisting of:
Figure BDA0003847565510000931
wherein k is an integer from 1 to 20; x 101 To X 108 Is C (including CH) or N; z 101 Is NAr 1 O or S; ar (Ar) 1 Having the same groups as defined above.
Examples of metal complexes used in HILs or HTLs include, but are not limited to, the following general formulas:
Figure BDA0003847565510000932
wherein Met is a metal which may have an atomic weight greater than 40; (Y) 101 -Y 102 ) Is a bidentate ligand, Y 101 And Y 102 Independently selected from C, N, O, P and S; l is 101 Is an ancillary ligand; k' is an integer value from 1 to the maximum number of ligands that can be attached to the metal; and k' + k "is the maximum number of ligands that can be attached to the metal.
In one aspect, (Y) 101 -Y 102 ) Is a 2-phenylpyridine derivative. In another aspect, (Y) 101 -Y 102 ) Is a carbene ligand. In another aspect, met is selected from Ir, pt, os and Zn. In another aspect, the metal complex has a structure comparable to Fc + A minimum oxidation potential in solution of less than about 0.6V for/Fc coupling.
Non-limiting examples of HIL and HTL materials that can be used in OLEDs in combination with the materials disclosed herein, along with references disclosing those materials, are exemplified by the following: CN102702075, DE102012005215, EP01624500, EP0169861, EP01806334, EP01930964, EP01972613, EP01997799, EP02011790, EP02055700, EP02055701, EP1725079, EP2085382, EP2660300, EP650955, JP07-073529, JP2005112765, JP2007091719, JP2008021687, JP2014-009196, KR20110088898, KR20130077473, TW 3920112011402, US06517957, US20020158242, US20030162053, US20050123751, US 20060160193, US 20060279, US20070145888, US 181874, US20070278938, US 20080014233464, US 20080091464, US 106190, US 20080145190, US 124145265, US 124145707, US 200802008020080434, US 20080220707 US20080303417, US2008107919, US20090115320, US20090167161, US2009066235, US2011007385, US20110163302, US2011240968, US2011278551, US2012205642, US2013241401, US20140117329, US2014183517, US5061569, US 56329914, WO05075451, WO07125714, WO08023550, WO08023759, WO2009145016, WO2010061824, WO 20115644, WO2012177006, WO2013018530, WO2013039073, WO2013087142, WO2013118812, WO 2010577, WO 201313175747, WO2014002873, WO2014015935, WO 030015937, WO 030030030030030030921, WO 20143120347018, WO 2014312018, WO 20142014201431247018, WO2014157018.
Figure BDA0003847565510000941
Figure BDA0003847565510000951
Figure BDA0003847565510000961
Figure BDA0003847565510000971
Figure BDA0003847565510000981
Figure BDA0003847565510000991
c)EBL:
An Electron Blocking Layer (EBL) may be used to reduce the number of electrons and/or excitons that leave the emissive layer. The presence of such a barrier layer in a device may result in substantially higher efficiency and/or longer lifetime compared to a similar device lacking a barrier layer. In addition, blocking layers can be used to limit the emission to the desired area of the OLED. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than the emitter closest to the EBL interface. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than one or more of the bodies closest to the EBL interface. In one aspect, the compound used in the EBL contains the same molecule or the same functional group as used in one of the hosts described below.
d) A main body:
the light-emitting layer of the organic EL device of the present disclosure preferably contains at least a metal complex as a light-emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complex or organic compound may be used as long as the triplet energy of the host is larger than that of the dopant. Any host material may be used with any dopant so long as the triplet criteria are met.
Examples of metal complexes used as hosts preferably have the following general formula:
Figure BDA0003847565510001001
wherein Met is a metal; (Y) 103 -Y 104 ) Is a bidentate ligand, Y 103 And Y 104 Independently selected from C, N, O, P and S; l is 101 Is another formulationA body; k' is an integer value from 1 to the maximum number of ligands that can be attached to the metal; and k' + k "is the maximum number of ligands that can be attached to the metal.
In one aspect, the metal complex is:
Figure BDA0003847565510001002
wherein (O-N) is a bidentate ligand having a metal coordinated to the O and N atoms.
In another aspect, met is selected from Ir and Pt. In another aspect, (Y) 103 -Y 104 ) Is a carbene ligand.
In one aspect, the host compound contains at least one selected from the group consisting of: a group consisting of aromatic hydrocarbon cyclic compounds such as: benzene, biphenyl, terphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, perylene,
Figure BDA0003847565510001003
Perylene and azulene; a group consisting of aromatic heterocyclic compounds such as: dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolobipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indolizine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furobipyridine, benzothienopyridine, thienobipyridine, benzoselenenopyridine, and selenenopyridine; and a group consisting of 2 to 10 cyclic structural units which are the same type or different types of groups selected from aromatic hydrocarbon ring groups and aromatic heterocyclic groups and are directly or via an oxygen atom, a nitrogen atom, sulfurAt least one of an atom, a silicon atom, a phosphorus atom, a boron atom, a chain structural unit and an aliphatic ring group is bonded to each other. Each option in each group may be unsubstituted or may be substituted with a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In one aspect, the host compound contains at least one of the following groups in the molecule:
Figure BDA0003847565510001011
wherein R is 101 Selected from the group consisting of: hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof, and when it is aryl or heteroaryl, it has a similar definition to Ar mentioned above. k is an integer from 0 to 20 or from 1 to 20. X 101 To X 108 Independently selected from C (including CH) or N. Z 101 And Z 102 Independently selected from NR 101 O or S.
Non-limiting examples of host materials that can be used in OLEDs in combination with the materials disclosed herein are exemplified below, along with references disclosing those materials: EP2034538, EP2034538A, EP2757608, JP2007254297, KR20100079458, KR20120088644, KR 20129733, KR20130115564, TW201329200, US20030175553, US20050238919, US20060280965, US20090017330, US20090030202, US20090167162, US20090302743, US20090309488, US20100012931, US20100084966, US20100187984, US 20187984, US2012075273, US2012126221, US2013009543, US2013105787, US2013175519, US 001446, US20140183503, US 20140228388, US20140225088 US2014034914, US7154114, WO2001039234, WO2004093207, WO2005014551, WO2005089025, WO2006072002, WO2006114966, WO2007063754, WO2008056746, WO2009003898, WO2009021126, WO2009063833, WO2009066778, WO2009066779, WO2009086028, WO2010056066, WO2010107244, WO 2011423, WO2011081431, WO2011086863, WO2012128298, WO2012133644, WO2012133649, WO2013024872, WO2013035275, WO2013081315, WO2013191404, WO 2011422014472, US20170263869, US20160163995, US9466803,
Figure BDA0003847565510001021
Figure BDA0003847565510001031
Figure BDA0003847565510001041
Figure BDA0003847565510001051
Figure BDA0003847565510001061
Figure BDA0003847565510001071
e) Other emitters:
one or more other emitter dopants may be used in combination with the compounds of the present invention. Examples of the other emitter dopant are not particularly limited, and any compound may be used as long as the compound is generally used as an emitter material. Examples of suitable emitter materials include, but are not limited to, compounds that can produce emission via phosphorescence, fluorescence, thermally activated delayed fluorescence (i.e., TADF, also known as E-type delayed fluorescence), triplet-triplet annihilation, or a combination of these processes.
Non-limiting examples of emitter materials that can be used in an OLED in combination with the materials disclosed herein, along with references disclosing those materials, are exemplified by the following: CN103694277, CN1696137, EB01238981, EP01239526, EP01961743, EP1239526, EP1244155, EP1642951, EP1647554, EP1841834B, EP2062907, EP2730583, JP2012074444, JP2013110263, JP4478555, KR1020090133652, KR20120032054, KR20130043460, TW201332980, US06699599, US06916554, US20010019782, US 20034656, US20030068526, US20030072964, US20030138657, US20050123788, US 200502673, US2005123791, US2005260449, US 60008670, US20060065890, US 200276016, US 2002734459, US 20034459 34459 US20060202194, US20060251923, US20070034863, US20070087321, US20070103060, US20070111026, US20070190359, US20070231600, US2007034863, US2007104979, US2007104980, US2007138437, US2007224450, US2007278936, US20080020237, US20080233410, US20080261076, US20080297033, US200805851, US2008161567, US2008210930, US 200900397676, US20090108737, US20090115322, US20090179555, US2009085476, US2009104, US20100090591, US20100148663, US20100244004, US20100295032, US2010102716, US 2015902 01002 US2010244004, US2010270916, US20110057559, US20110108822, US20110204333, US2011215710, US2011227049, US2011285275, US2012292601, US20130146848, US2013033172, US2013165653, US2013181190, US2013334521, US20140246656, US2014103305, US6303238, US6413656, US6653654, US6670645, US6687266, US6835469, US6921915, US 9704, US 7332232232, US7378162, US 7274505, US 7675070228, US7728137, US7740957, US7759489, US7951947, US8067099, US8592586, US8871361, WO 8881973, WO 06111, WO 06167 18067, WO 18018067, US 1801801801801801809, US 94361 WO07108362, WO07115970, WO07115981, WO08035571, WO2002015645, WO2003040257, WO2005019373, WO2006056418, WO2008054584, WO2008078800, WO2008096609, WO2008101842, WO2009000673, WO2009050281, WO2009100991, WO 0028151, WO2010054731, WO2010086089, WO2010118029, WO2011044988, WO2011051404, WO2011107491, WO 2012010327, WO2012163471, WO2013094620, WO2013107487, WO2013174471, WO2014007565, WO2014008982, WO 20142014377, WO 024131, WO2014031977, WO2014038456, WO2014112450.
Figure BDA0003847565510001081
Figure BDA0003847565510001091
Figure BDA0003847565510001101
Figure BDA0003847565510001111
Figure BDA0003847565510001121
f)HBL:
Hole Blocking Layers (HBLs) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a barrier layer in a device may result in substantially higher efficiency and/or longer lifetime compared to a similar device lacking a barrier layer. In addition, blocking layers can be used to limit the emission to the desired area of the OLED. In some embodiments, the HBL material has a lower HOMO (farther from the vacuum level) and/or higher triplet energy than the emitter closest to the HBL interface. In some embodiments, the HBL material has a lower HOMO (farther from the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the HBL interface.
In one aspect, the compound used in the HBL contains the same molecule or the same functional group as used for the host described above.
In another aspect, the compound used in HBL contains in the molecule at least one of the following groups:
Figure BDA0003847565510001131
wherein k is an integer from 1 to 20; l is 101 Is another ligand, and k' is an integer of 1 to 3.
g)ETL:
The Electron Transport Layer (ETL) may include a material capable of transporting electrons. The electron transport layer may be intrinsic (undoped) or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complex or organic compound may be used as long as it is generally used to transport electrons.
In one aspect, the compound used in the ETL contains in the molecule at least one of the following groups:
Figure BDA0003847565510001132
wherein R is 101 Selected from the group consisting of: hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof, which when aryl or heteroaryl has a similar definition to Ar described above. Ar (Ar) 1 To Ar 3 Have similar definitions as Ar mentioned above. k is an integer of 1 to 20. X 101 To X 108 Selected from C (including CH) or N.
In another aspect, the metal complex used in the ETL contains (but is not limited to) the following general formula:
Figure BDA0003847565510001141
wherein (O-N) or (N-N) is a bidentate ligand having a metal coordinated to the atom O, N or N, N; l is 101 Is another ligand; k' is an integer value from 1 to the maximum number of ligands that can be attached to the metal.
Non-limiting examples of ETL materials that can be used in an OLED in combination with the materials disclosed herein, along with references disclosing those materials, are exemplified as follows: CN103508940, EP01602648, EP01734038, EP01956007, JP2004-022334, JP2005149918, JP2005-268199, KR0117693, KR20130108183, US20040036077, US20070104977, US2007018155, US20090101870, US20090115316, US20090140637, US20090179554, US2009218940, US2010108990, US2011156017, US2011210320, US2012193612, US2012214993, US 20140142014014925, US 201401492014927, US 2014028450284580, US 5666612, US 848431, WO 2003063063063063060956, WO2007111263, WO2009148269, WO2010067894, WO2010072300, WO 201107070, WO 105373, WO 201304530453017, WO 20131454545150376, WO 201104104667 376, WO2014104535, WO2014 535, WO2014104535,
Figure BDA0003847565510001142
Figure BDA0003847565510001151
Figure BDA0003847565510001161
h) Charge Generation Layer (CGL)
In tandem or stacked OLEDs, CGL plays a fundamental role in performance, consisting of an n-doped layer and a p-doped layer for injecting electrons and holes, respectively. Electrons and holes are supplied by the CGL and the electrodes. Electrons and holes consumed in the CGL are refilled by electrons and holes injected from the cathode and anode, respectively; subsequently, the bipolar current gradually reaches a steady state. Typical CGL materials include n and p conductivity dopants used in the transport layer.
In any of the above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms may be partially or fully deuterated. The minimum amount of hydrogen of the deuterated compound is selected from the group consisting of 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 99%, and 100%. Thus, any of the specifically listed substituents, such as (but not limited to) methyl, phenyl, pyridyl, and the like, can be in their non-deuterated, partially deuterated, and fully deuterated forms. Similarly, substituent classes (such as, but not limited to, alkyl, aryl, cycloalkyl, heteroaryl, etc.) can also be non-deuterated, partially-deuterated, and fully-deuterated forms thereof.
It should be understood that the various embodiments described herein are by way of example only and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without departing from the spirit of the present invention. The invention as claimed may thus comprise variations of the specific examples and preferred embodiments described herein, as will be apparent to those skilled in the art. It should be understood that various theories as to why the invention works are not intended to be limiting.
Experimental data
Figure BDA0003847565510001171
Synthesis of emitter 7
N 1 - (3, 3' -bis (tris (phenyl-d) 5 ) Silyl) - [1,1':3', 1' -terphenyl]-2' -yl-2, 2", 4", 5", 6" -d 8 ) Synthesis of benzene-1, 2-diamine: (3- (tris (phenyl-d) 5 ) Silyl) phenyl-2, 4,5,6-d 4 ) A solution of boric acid (60g, 150mmol,1 eq), 2, 6-dibromo-N- (2-nitrophenyl) aniline (26g, 69.9mmol,0.465 eq), potassium carbonate (25g, 180mmol,1.2 eq), and Sphos Pd G2 THF adduct (2g, 2.4mmol,0.016 eq) in a mixture of toluene (600 mL), 2-propanol (60 mL), and water (60 mL) was bubbled with nitrogen at Room Temperature (RT) for 30 minutes. The suspension was heated at reflux for 18 hours. The reaction was cooled to about 50 ℃ and partitioned. Toluene for aqueous layer(100 mL) was extracted. The combined organic layers were then washed with water (2 × 100 mL) and concentrated under reduced pressure. The suspension was heated at 50 ℃ and hydrazine hydrate (100mL, 3.12mol,44.6 equivalents) was added dropwise over 2 hours. After a further two days, the suspension was cooled to room temperature and filtered through a pad of Celite (100 g). The filtrate was partitioned and the aqueous layer was extracted with toluene (2X 100 mL). The combined organic layers were filtered through filter paper and concentrated under reduced pressure to give N 1 - (3, 3' -bis (tris (phenyl-d) 5 ) Silyl) - [1,1':3', 1' -terphenyl]-2' -yl-2, 2", 4",5,5 ', 6 ' -d 8 ) Benzene-1, 2-diamine (56.1 g, 90% yield over two steps).
N 1 - (3, 3' -bis (tris (phenyl-d) 5 ) Silyl) - [1,1':3', 1' -terphenyl]-2' -yl-2, 2", 4", 5", 6" -d 8 ) -synthesis of N2- (3- ((9- (4- (tert-butyl) pyridin-2-yl) -9H-carbazol-2-yl) oxy) phenyl) benzene-1, 2-diamine: compound N 1 - (3, 3' -bis (tris (phenyl-d) 5 ) Silyl) - [1,1':3', 1' -terphenyl]-2' -yl-2, 2", 4",5,5 ', 6 ' -d 8 ) Benzene-1, 2-diamine (25g, 28mmol,1 eq), 2- (3-bromophenoxy) -9- (4- (tert-butyl) pyridin-2-yl) -9H-carbazole (14.53g, 30.8mmol,1.1 eq), sodium tert-butoxide (5.38g, 56mmol,2 eq) and [1,1' -bis (di-tert-butylphosphino) ferrocene]A solution of palladium (II) dichloride (0.9g, 1.4mmol,0.05 eq.) in toluene (280 mL) was bubbled with nitrogen for 20 minutes. The reaction mixture was heated at 110 ℃ for 18 hours. Water (10 mL) was added to quench the reaction, and the black suspension was filtered through a pad of Celite (100 g) and washed with toluene (2X 50 mL). The filtrate was partitioned, and the organic layer was concentrated under reduced pressure to give an oil. Purifying the crude product by column chromatography to obtain compound N 1 - (3, 3' -bis (tris (phenyl-d) 5 ) Silyl) - [1,1':3', 1' -terphenyl]-2' -yl-2, 2", 4",5,5 ', 6 ' -d 8 ) -N2- (3- ((9- (4- (tert-butyl) pyridin-2-yl) -9H-carbazol-2-yl) oxy) phenyl) benzene-1, 2-diamine (32g, 62% yield).
2- (3- (3, 3' -bis (tris (phenyl-d)) 5 ) Silyl) - [1,1':3', 1' -terphenyl]-2' -yl-2, 2", 4", 5", 6" -d 8 ) -2-bromo-2, 3-dihydro-1H-benzo [ d]Imidazol-1-yl) phenoxy) -9- (4- (tert-butyl) pyridine-synthesis of 2-yl) -9H-carbazole: n is a radical of 1 - (3, 3' -bis (tris (phenyl-d) 5 ) Silyl) - [1,1':3', 1' -terphenyl]-2' -yl-2, 2", 4", 5", 6" -d 8 ) -N2- (3- ((9- (4- (tert-butyl) pyridin-2-yl) -9H-carbazol-2-yl) oxy) phenyl) benzene-1, 2-diamine (36.5g, 28.4 mmol) was stirred at room temperature with triethyl orthoformate (100g, 675mmol,23.7 equivalents) and hydrobromic acid (6.39mL, 48% aq, 2 equivalents) for 18 hours. Diethyl ether (300 mL) was added dropwise to dilute the slurry. The solid was filtered under vacuum and washed with diethyl ether (2X 100 mL) to give 2- (3- (3, 3' -bis (tris (phenyl-d) 5 ) Silyl) - [1,1':3', 1' -terphenyl]-2' -yl-2, 2", 4", 5", 6" -d 8 ) -2-bromo-2, 3-dihydro-1H-benzo [ d]Imidazol-1-yl) phenoxy) -9- (4- (tert-butyl) pyridin-2-yl) -9H-carbazole (26.5g, 68% yield).
Synthesis of emitter 7: 2- (3- (3, 3' -bis (tris (phenyl-d)) 5 ) Silyl) - [1,1':3', 1' -terphenyl]-2' -yl-2, 2", 4", 5", 6" -d 8 ) -2-bromo-2, 3-dihydro-1H-benzo [ d]Imidazol-1-yl) phenoxy) -9- (4- (tert-butyl) pyridin-2-yl) -9H-carbazole (24.5g, 17.8mmol) was suspended in an organic solvent (93 mL). The suspension was bubbled with nitrogen for 20 minutes while adding the base (1.1 equiv) and platinum precursor (1.05 equiv). The suspension was refluxed at 145 ℃ for five hours. The slurry was cooled to room temperature and methanol (300 mL) was added over 10 minutes and filtered. The crude product was purified by column chromatography to give complex 1 (22.7g, 82% yield).
Synthesis of emitter 2
N- (2-Nitrophenyl) -2, 6-bis (5, 8-tetrakis (methyl-d) 3 ) -5,6,7,8-tetrahydronaphthalen-2-yl-1, 3,4,6,6,7,7-d 7 ) And (3) aniline synthesis: 4, 5-tetramethyl-2- (5, 8-tetra (methyl-d) 3 ) -5,6,7,8-tetrahydronaphthalen-2-yl-1, 3,4,6,6,7,7-d 7 ) A solution of-1, 3, 2-dioxaborolane (100g, 299mmol,1.0 equiv.), 2, 6-dibromo-N- (2-nitrophenyl) aniline (50g, 134mmol,0.45 equiv.), SPhos G2 (5.1g, 7.5mmol,0.025 equiv.), and potassium carbonate (51.6G, 373mmol,1.25 equiv.) in 1, 4-dioxane (1.4L) and water (150 mL) was bubbled with nitrogen for 20 minutes. The reaction was heated at reflux for 18 hours. The reaction mixture was cooled to room temperature and addedWater (1L). The mixture was extracted with toluene (3 × 500 mL) and the combined organic layers were concentrated under reduced pressure. The orange solid was purified by column chromatography to give the compound N- (2-nitrophenyl) -2, 6-bis (5, 8-tetrakis (methyl-d) 3 ) -5,6,7,8-tetrahydronaphthalen-2-yl-1, 3,4,6,6,7,7-d 7 ) Aniline (68 g, 80% yield).
N 1 - (2, 6-bis (5, 8-tetrakis (methyl-d) 3 ) -5,6,7,8-tetrahydronaphthalen-2-yl-1, 3,4,6,6,7,7-d 7 ) Phenyl) Synthesis of benzene-1, 2-diamine: n- (2-Nitrophenyl) -2, 6-bis (5, 8-tetrakis (methyl-d) 3 ) -5,6,7,8-tetrahydronaphthalen-2-yl-1, 3,4,6,6,7,7-d 7 ) A solution of aniline (68g, 109mmol,1.0 equiv.) in THF (800 mL) and 2-propanol (200 mL) was bubbled with nitrogen for 20 minutes. 10% Pd/C,50% wet (24.2g, 12.1mmol,0.05 equiv) was added, followed by a solution of ammonium formate (122g, 1934mmol,8 equiv) in water (160 mL). The reaction mixture was stirred at 50 ℃ for 18 hours. The reaction was cooled to room temperature and water (2L) was added. The mixture was purified by column chromatography to give N 1 - (2, 6-bis (5, 8-tetrakis (methyl-d) 3 ) -5,6,7,8-tetrahydronaphthalen-2-yl-1, 3,4,6,6,7,7-d 7 ) Phenyl) benzene-1, 2-diamine (64.6 g,99% yield).
N 1 - (2, 6-bis (5, 8-tetrakis (methyl-d) 3 ) -5,6,7,8-tetrahydronaphthalen-2-yl-1, 3,4,6,6,7,7-d 7 ) Phenyl) -N 2 Synthesis of- (3- ((9- (4- (tert-butyl) pyridin-2-yl) -9H-carbazol-2-yl) oxy) phenyl) benzene-1, 2-diamine: 2- (3-bromophenoxy) -9- (4- (tert-butyl) pyridin-2-yl) -9H-carbazole (21.4g, 45.5mmol,1.0 equiv.), N 1 - (2, 6-bis (5, 8-tetrakis (methyl-d) 3 ) -5,6,7,8-tetrahydronaphthalen-2-yl-1, 3,4,6,6,7,7-d 7 ) Phenyl) benzene-1, 2-diamine (27g, 45.5mmol,1.0 equiv), [1,1' -bis (diphenylphosphino) ferrocene]A solution of dichloropalladium (II) complex with dichloromethane (7.41g, 9.1mmol,0.2 equiv.) and sodium tert-butoxide (8.7 g,91mmol,2.0 equiv.) in toluene (230 mL) was bubbled with nitrogen for 20 minutes. The reaction mixture was heated at reflux for 18 hours. The reaction mixture was cooled to room temperature and water (500 mL) was added. The mixture was filtered and the filtrate layer was separated. The aqueous layer was extracted with dichloromethane (3X 100 mL). The combined organic layers were concentrated under reduced pressure. The crude product is purified by column chromatographyTo obtain N 1 - (2, 6-bis (5, 8-tetrakis (methyl-d) 3 ) -5,6,7,8-tetrahydronaphthalen-2-yl-1, 3,4,6,6,7,7-d 7 ) Phenyl) -N 2 - (3- ((9- (4- (tert-butyl) pyridin-2-yl) -9H-carbazol-2-yl) oxy) phenyl) benzene-1, 2-diamine (60 g, quantitative yield).
1- (2, 6-bis (5, 8-tetrakis (methyl-d) 3 ) -5,6,7, 8-tetrahydronaphthalen-2-yl-1, 3,4,6,6, 7-d 7) phenyl) -3- (3- ((9- (4- (tert-butyl) pyridin-2-yl) -9H-carbazol-2-yl) oxy) phenyl) -1-chloro-2, 3-dihydro-1H-benzo [ d]Synthesis of imidazol-1-ium-2-ide: n is a radical of 1 - (2, 6-bis (5, 8-tetrakis (methyl-d) 3 ) -5,6,7,8-tetrahydronaphthalen-2-yl-1, 3,4,6,6,7,7-d 7 ) Phenyl) -N 2 A solution of (3- ((9- (4- (tert-butyl) pyridine)) -2-yl) -9H-carbazol-2-yl) oxy) phenyl) benzene-1, 2-diamine (48g, 48.7mmol,1.0 eq) in triethyl orthoformate (162mL, 974mmol,20 eq) was bubbled with nitrogen for 20 min. Hydrochloric acid (4.87mL, 58.4mmol,1.2 equiv.) was added and the reaction mixture was stirred at 80 ℃ for 18 h. The reaction was cooled to room temperature and concentrated under reduced pressure. MTBE (500 mL) was added and stirred for 3 hours to form a precipitate. The solid was filtered to give 1- (2, 6-bis (5, 8-tetrakis (methyl-d) 3 ) -5,6,7, 8-tetrahydronaphthalen-2-yl-1, 3,4,6,6, 7-d 7) phenyl) -3- (3- ((9- (4- (tert-butyl) pyridin-2-yl) -9H-carbazol-2-yl) oxy) phenyl) -1-chloro-2, 3-dihydro-1H-benzo [ d]Imidazol-1-ium-2-ide (43g, 85% yield).
Synthesis of emitter 2: 1- (2, 6-bis (5, 8-tetrakis (methyl-d) 3 ) -5,6,7, 8-tetrahydronaphthalen-2-yl-1, 3,4,6,6, 7-d 7) phenyl) -3- (3- ((9- (4- (tert-butyl) pyridin-2-yl) -9H-carbazol-2-yl) oxy) phenyl) -1-chloro-2, 3-dihydro-1H-benzo [ d]A mixture of imidazole-1-onium-2-compound (40g, 38.8mmol,1.0 eq.) and platinum precursor (1.0 eq.) in solvent (130 mL) was sparged with nitrogen for 20 minutes. Base (1.1 eq) was added and the mixture was stirred at reflux for 18 h. The reaction mixture was cooled to room temperature and concentrated under reduced pressure. The material was purified by column chromatography to give emitter 2 (17.4g, 38% yield).
Table 1 below provides the properties (λ max and PLQY) of the emitter compounds of the invention (emitters 1 to 7) and the comparative emitter compounds (emitter 8) used in the test devices.
Table 1: photoluminescence properties of PMMA films of the compound.
Compound (I) λ max (nm) PLQY
Projectile 1 456 0.92
Projectile body 2 455 0.93
Projectile body 3 457 0.85
Projectile body 4 456 0.92
Projectile body 5 457 0.9
Projectile body 6 457 0.88
Projectile 7 456 0.85
Emitter 8 (comparison) 455 0.8
The compounds of the invention with more sterically hindered groups emitter 2, emitter 3, emitter 5, emitter 6 and emitter 7 showed more efficient emission relative to emitter 8 (comparative compound): the increase in photoluminescence quantum yield (PLQY) was between 6% and 16%. Compounds 1 and 4 of the invention have a more rigid group on the N atom of the benzimidazolium carbene, and higher PLQY was also reported relative to the comparative compound. The peak emission wavelength of the Polymethylmethacrylate (PMMA) film is similar to the comparative compound, resulting in the deep blue emission required for efficient blue phosphorescent OLED technology.
Emission spectra were collected on a Horiba Fluorolog-3 fluorescence spectrophotometer equipped with a Synapse Plus CCD detector. All samples were excited at 340 nm. PLQY values were measured using a Hamamatsu Quantaurus-QY Plus UV-NIR absolute PL quantum yield spectrometer with an excitation wavelength of 340 nm. A solution of 1% emitter and PMMA in toluene was prepared, filtered and drop cast onto a quartz substrate.
Color and efficiency are very important in rendering deep blue emission for blue Organic Light Emitting Devices (OLEDs). In addition to the photophysical data, OLEDs were fabricated to compare the efficiency and color of emitters 1 and 7 used in devices 1-7 and comparison device 8 using comparison emitter compound emitter 8. The results of the device EQE, peak wavelength, FWHM and color coordinates are summarized in table 2 below. The arrangement of emitters 1 through 7 exhibits a more blue color, increased EQE and narrower emission. These are all properties that are important in optimizing the presentation of deep blue emitting microcavity devices. Without being bound by any theory, the emitter complexes of the invention exhibit an improvement in color due to the design of the substitutions on the complex scaffold. The bulky substituents may reduce the rate of non-radiative decay and harden the complex, resulting in higher efficiency and narrower emission. The improvement in these values is greater than the variation attributable to experimental error, so the observed improvement is significant.
Table 2: electroluminescent properties of OLEDs comprising the compounds.
Figure BDA0003847565510001211
The OLEDs tested were grown on glass substrates pre-coated with a layer of Indium Tin Oxide (ITO) with a sheet resistance of 15- Ω/sq. Prior to any organic layer deposition or coating, the substrate was degreased with a solvent, then treated with an oxygen plasma at 100 mtorr for 1.5 minutes at 50W, and treated with UV ozone for 5 minutes. The OLEDs tested were under high vacuum (C:)<10 -6 Tray) by thermal evaporation. The anode electrode is
Figure BDA0003847565510001212
Indium Tin Oxide (ITO). An example device has an organic layer consisting of, in order from the ITO surface:
Figure BDA0003847565510001213
compound 1 (HIL),
Figure BDA0003847565510001214
Compound 2 (HTL),
Figure BDA0003847565510001215
Compound 3 (EBL),
Figure BDA0003847565510001216
Compound 3 doped with 50% of compound 4 and 12% of Emitter (EML),
Figure BDA0003847565510001217
Compound 4 (BL),
Figure BDA0003847565510001218
Compound 5 (ETL) doped with 35% of compound 6,
Figure BDA0003847565510001219
Figure BDA00038475655100012110
Compound 5 (EIL) followed by
Figure BDA00038475655100012111
Al (cathode). All devices were placed in a nitrogen glove box immediately after manufacture ((S))<1ppm of H 2 O and O 2 ) The glass cover is sealed by epoxy resin, and moisture absorbent is added in the package. The doping percentages are expressed in volume percent.
The materials used in the device were as follows:
Figure BDA0003847565510001221
Figure BDA0003847565510001231

Claims (15)

1. a compound of the formula I, wherein,
Figure FDA0003847565500000011
wherein:
each of rings B, C and D is independently a 5-or 6-membered carbocyclic or heterocyclic ring;
Z 1 、Z 2 and Z 3 One is N and the remainder are C;
L 1 and L 2 Each of which is independently selected from the group consisting of: direct bond, BR, BRR ', NR, PR, P (O) R, O, S, se, C = O, C = S, C = Se, C = NR ', C = CR ' R ", S = O, SO 2 CR, CRR ', siRR ', geRR ', alkylene, cycloalkyl, aryl, cycloalkylene, arylene, heteroarylene, and combinations thereof;
R 1 、R 2 、R A 、R B 、R C 、R D and R E Comprises a group R having a structure selected from the group consisting of * : formula II, - - - -Q (R) 3 )(R 4 ) a (R 5 ) b (ii) a In the formula (III), the compound is shown in the formula,
Figure FDA0003847565500000012
and a compound of the formula IV,
Figure FDA0003847565500000013
R A 、R B 、R C 、R D 、R E 、R F 、R G 、R H each independently represents mono-to maximum permissible substitution or no substitution;
each R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H Independently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, seleno, and combinations thereof;
X 1 to X 20 Each of which is independently C or N;
Y A 、Y B and Y C Each of which is independently CRR 'or SiRR';
n is an integer between 1 and 4;
q is selected from C, si, N, O and B;
a and b are each independently 0 or 1;
when Q is C or Si, a + b =2;
when Q is N or B, a + B =1;
when Q is O, a + b =0;
when Q is Si, N, O or B, R 3 、R 4 Or R 5 At least one of the groups comprises deuterium;
when Q is C, R 3 、R 4 And R 5 Independently selected from the group consisting of: alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, and combinations thereof, which may be fully or partially deuterated, and at least one of the following four conditions is true:
(i)R 1 and R 2 Are not hydrogen, and the radical R * Comprising at least five carbon atoms, and,
(ii)R 1 and R 2 Is hydrogen, and the radical R * Containing at least ten carbon atoms, or
(iii)R 3 And R 4 Joined to form a ring, and R 5 In addition to the hydrogen, the aromatic ring is,
(iv)R * containing five or more carbon atoms, and R 3 、R 4 And R 5 At least one of which comprises deuterium;
when R is * Is formula IV, at least one of the following two conditions is true:
(a) At least one R H Is a substituent other than hydrogen or deuterium, and at least one R H Is deuterium;
(b)X 12 to X 16 Is N, and at least one R H Is deuterium;
any two of R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H May be joined or fused to form a ring; and is
Any two of R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H May be joined or fused to form a ring, with the proviso that the group R * Is not adamantyl.
2. The compound of claim 1, wherein each R, R', R ", R 1 、R 2 、R A 、R B 、R C 、R D 、R E 、R F And R G Independently hydrogen or a substituent selected from the group consisting of: deuterium, fluoro, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, thio, and combinations thereof.
3. The compound of claim 1, wherein the compound has the structure of formula IA:
Figure FDA0003847565500000031
wherein X 4 ' to X 15 Each of' is independently C or N.
4. The compound of claim 1, wherein L 1 Selected from the group consisting of O, S and Se, and L 2 Selected from the group consisting of BR and NR.
5. The compound of claim 1, wherein R 1 Or R 2 At least one of which comprises a group R *
6. According to the rightA compound according to claim 1, wherein at least one group R * Has the structure shown in the formula II,
wherein the radical R * Selected from the group consisting of:
Figure FDA0003847565500000041
Figure FDA0003847565500000051
Figure FDA0003847565500000061
Figure FDA0003847565500000071
Figure FDA0003847565500000081
Figure FDA0003847565500000091
Figure FDA0003847565500000101
wherein R is a1 And R a2 Independently selected from the group consisting of:
Figure FDA0003847565500000102
Figure FDA0003847565500000103
Figure FDA0003847565500000111
Figure FDA0003847565500000112
and is
Wherein R is l 、R m 、R n 、R o Each of which is independently selected from the group consisting of:
Figure FDA0003847565500000113
Figure FDA0003847565500000121
Figure FDA0003847565500000131
Figure FDA0003847565500000141
Figure FDA0003847565500000151
Figure FDA0003847565500000161
Figure FDA0003847565500000171
Figure FDA0003847565500000181
Figure FDA0003847565500000191
Figure FDA0003847565500000201
Figure FDA0003847565500000211
Figure FDA0003847565500000221
Figure FDA0003847565500000231
Figure FDA0003847565500000241
Figure FDA0003847565500000251
Figure FDA0003847565500000261
Figure FDA0003847565500000271
Figure FDA0003847565500000281
Figure FDA0003847565500000291
Figure FDA0003847565500000301
7. the compound of claim 1, wherein the compound has a structure selected from the group consisting of:
Figure FDA0003847565500000311
Figure FDA0003847565500000321
8. the compound of claim 1, wherein X 1 To X 20 Each of which is C; and/or
Wherein X 4 ' to X 7 Each of' is C; and/or
X 8 ' to X 10 Each of' is C; and/or
X 11 ' to X 13 Each of' is C; and/or
X 14 ' to X 15 Each of' is C; and/or
X 16 ' to X 19 Each of' is C.
9. The compound of claim 3, wherein X 1 To X 20 Is N; and/or
X 4 ' toX 7 At least one of is N; and/or
X 8 ' to X 10 At least one of is N; and/or
X 11 ' to X 13 At least one of is N; and/or
X 14 ' to X 15 At least one of is N; and/or
X 16 ' to X 19 At least one of is N.
10. The compound of claim 1, wherein the compound is selected from the group consisting of compounds having the formula Pt (L) A' ) (Ly) a group consisting of compounds of (Ly):
Figure FDA0003847565500000331
wherein L is A' Selected from the group consisting of:
Figure FDA0003847565500000332
Figure FDA0003847565500000341
wherein L is y Selected from the group consisting of:
Figure FDA0003847565500000342
Figure FDA0003847565500000351
Figure FDA0003847565500000361
wherein Ph represents a phenyl group;
wherein each R 1 、R 2 、R A 、R B 、R E 、R F 、R Q '、R R '、R S '、R T '、R X 、R X ' and R Y Independently selected from the group consisting of:
Figure FDA0003847565500000362
Figure FDA0003847565500000363
Figure FDA0003847565500000371
Figure FDA0003847565500000381
Figure FDA0003847565500000391
Figure FDA0003847565500000401
Figure FDA0003847565500000411
Figure FDA0003847565500000421
Figure FDA0003847565500000431
Figure FDA0003847565500000441
Figure FDA0003847565500000451
Figure FDA0003847565500000461
Figure FDA0003847565500000471
Figure FDA0003847565500000481
Figure FDA0003847565500000491
Figure FDA0003847565500000501
Figure FDA0003847565500000511
Figure FDA0003847565500000521
Figure FDA0003847565500000531
Figure FDA0003847565500000541
Figure FDA0003847565500000551
Figure FDA0003847565500000561
Figure FDA0003847565500000562
wherein R is a1 And R a2 Independently selected from the group consisting of:
Figure FDA0003847565500000563
Figure FDA0003847565500000564
Figure FDA0003847565500000571
the compound is selected from the group consisting of compounds having the formula Pt (L) A' ) (Ly) a compound of the group consisting of:
Figure FDA0003847565500000572
wherein L is A' Selected from the group consisting of:
Figure FDA0003847565500000573
Figure FDA0003847565500000581
wherein L is y Selected from the group consisting of:
Figure FDA0003847565500000582
Figure FDA0003847565500000591
Figure FDA0003847565500000601
Figure FDA0003847565500000611
wherein each of q, r, s, t, u, v, w, z, a ', b', c ', d', e ', t', v ', w' is independently an integer from 1 to 658;
wherein R1 through R658 have the following structures:
Figure FDA0003847565500000612
Figure FDA0003847565500000613
Figure FDA0003847565500000621
Figure FDA0003847565500000631
Figure FDA0003847565500000641
Figure FDA0003847565500000651
Figure FDA0003847565500000661
Figure FDA0003847565500000671
Figure FDA0003847565500000681
Figure FDA0003847565500000691
and R209 to R658 are defined as follows:
Figure FDA0003847565500000692
Figure FDA0003847565500000701
wherein A1 to A25 have the following structures:
Figure FDA0003847565500000702
Figure FDA0003847565500000703
11. the compound of claim 1, wherein the compound is selected from the group consisting of:
Figure FDA0003847565500000704
Figure FDA0003847565500000711
Figure FDA0003847565500000721
Figure FDA0003847565500000731
Figure FDA0003847565500000741
Figure FDA0003847565500000751
Figure FDA0003847565500000761
Figure FDA0003847565500000771
Figure FDA0003847565500000781
Figure FDA0003847565500000791
Figure FDA0003847565500000801
Figure FDA0003847565500000811
Figure FDA0003847565500000821
Figure FDA0003847565500000831
Figure FDA0003847565500000841
Figure FDA0003847565500000851
Figure FDA0003847565500000861
Figure FDA0003847565500000871
Figure FDA0003847565500000881
Figure FDA0003847565500000891
Figure FDA0003847565500000901
Figure FDA0003847565500000911
Figure FDA0003847565500000921
Figure FDA0003847565500000931
12. an Organic Light Emitting Device (OLED), comprising:
an anode;
a cathode; and
an organic layer disposed between the anode and the cathode, wherein the organic layer comprises a compound of formula I:
Figure FDA0003847565500000932
wherein:
each of rings B, C and D is independently a 5-or 6-membered carbocyclic or heterocyclic ring;
Z 1 、Z 2 and Z 3 One is N and the others are C;
L 1 and L 2 Each of which is independently selected from the group consisting of: direct bond, BR, BRR ', NR, PR, P (O) R, O, S, se, C = O, C = S, C = Se, C = NR ', C = CR ' R ", S = O, SO 2 CR, CRR ', siRR ', geRR ', alkylene, cycloalkyl, aryl, cycloalkylene, arylene, heteroarylene, and combinations thereof;
R 1 、R 2 、R A 、R B 、R C 、R D and R E Comprises a group R having a structure selected from the group consisting of * : formula II, - - - -Q (R) 3 )(R 4 ) a (R 5 ) b (ii) a In the formula (III), the compound is shown in the formula,
Figure FDA0003847565500000941
and a compound of the formula IV,
Figure FDA0003847565500000942
R A 、R B 、R C 、R D 、R E 、R F 、R G 、R H each independently represents mono-to maximum permissible substitution or no substitution;
each R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H Independently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, seleno, and combinations thereof;
X 1 to X 20 Each of which is independently C or N;
Y A 、Y B and Y C Each of which is independently CRR 'or SiRR';
n is an integer between 1 and 4;
q is selected from C, si, N, O and B;
a and b are each independently 0 or 1;
when Q is C or Si, a + b =2;
when Q is N or B, a + B =1;
when Q is O, a + b =0;
when Q is Si, N, O or B, R 3 、R 4 Or R 5 At least one of the groups comprises deuterium;
when Q is C, R 3 、R 4 And R 5 Independently selected from the group consisting of: alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, and combinations thereof, which may be fully or partially deuterated, and at least one of the following four conditions is true:
(i)R 1 and R 2 Are not hydrogen, and the radical R * Comprising at least five carbon atoms, and,
(ii)R 1 and R 2 Is hydrogen, and the radical R * Containing at least ten carbon atoms, or
(iii)R 3 And R 4 Joined to form a ring, and R 5 In addition to the hydrogen, the aromatic ring is,
(iv)R * containing five or more carbon atoms, and R 3 、R 4 And R 5 At least one of which comprises deuterium;
when R is * Is formula IV, at least one of the following two conditions is true:
(a) At least one R H Is a substituent other than hydrogen or deuterium, and at least one R H Is deuterium;
(b)X 12 to X 16 Is N, and at least one R H Is deuterium;
any two of R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H May be joined or fused to form a ring; and is
Any two of R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H May be joined or fused to form a ring, with the proviso that the group R * Is not adamantyl.
13. The OLED according to claim 12, wherein the organic layer further comprises a host, wherein the host comprises at least one chemical moiety selected from the group consisting of: triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5 λ 2-benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole, 5, 9-dioxa-13 b-boronaphtho [3,2,1-de ] anthracene, triazine, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-5 λ 2-benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole, and aza- (5, 9-dioxa-13 b-boronaphtho [3,2,1-de ] anthracene).
14. The OLED of claim 13 wherein the host is selected from the group consisting of:
Figure FDA0003847565500000951
Figure FDA0003847565500000961
Figure FDA0003847565500000971
Figure FDA0003847565500000972
and combinations thereof.
15. A consumer product comprising an organic light emitting device, the organic light emitting device comprising:
an anode;
a cathode; and
an organic layer disposed between the anode and the cathode, wherein the organic layer comprises a compound of formula I:
Figure FDA0003847565500000973
wherein:
each of rings B, C and D is independently a 5-or 6-membered carbocyclic or heterocyclic ring;
Z 1 、Z 2 and Z 3 One is N and the others are C;
L 1 and L 2 Each of which is independently selected from the group consisting of: direct bond, BR, BRR ', NR, PR, P (O) R, O, S, se, C = O, C = S, C = Se, C = NR ', C = CR ' R ", S = O, SO 2 CR, CRR ', siRR ', geRR ', alkylene, cycloalkyl, aryl, cycloalkylene, arylene, heteroarylene, and combinations thereof;
R 1 、R 2 、R A 、R B 、R C 、R D and R E Comprises a group R having a structure selected from the group consisting of * : formula II, - - - -Q (R) 3 )(R 4 ) a (R 5 ) b (ii) a In the formula (III), the compound is shown in the formula,
Figure FDA0003847565500000981
and a compound of the formula IV,
Figure FDA0003847565500000982
R A 、R B 、R C 、R D 、R E 、R F 、R G 、R H each of which independently represents a single substitution to the maximum allowable substitutionSubstituted or unsubstituted;
each R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H Independently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, seleno, and combinations thereof;
X 1 to X 20 Each is independently C or N;
Y A 、Y B and Y C Each of which is independently CRR 'or SiRR';
n is an integer between 1 and 4;
q is selected from C, si, N, O and B;
a and b are each independently 0 or 1;
when Q is C or Si, a + b =2;
when Q is N or B, a + B =1;
when Q is O, a + b =0;
when Q is Si, N, O or B, R 3 、R 4 Or R 5 At least one of the groups comprises deuterium;
when Q is C, R 3 、R 4 And R 5 Independently selected from the group consisting of: alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, and combinations thereof, which may be fully or partially deuterated, and at least one of the following four conditions is true:
(i)R 1 and R 2 Are not hydrogen, and the radical R * Comprising at least five carbon atoms, and,
(ii)R 1 and R 2 Is hydrogen, and the radical R * Containing at least ten carbon atoms, or
(iii)R 3 And R 4 Joined to form a loop which,and R is 5 In addition to the hydrogen, the aromatic ring is,
(iv)R * containing five or more carbon atoms, and R 3 、R 4 And R 5 At least one of which comprises deuterium;
when R is * Is formula IV, at least one of the following two conditions is true:
(a) At least one R H Is a substituent other than hydrogen or deuterium, and at least one R H Is deuterium;
(b)X 12 to X 16 Is N, and at least one R H Is deuterium;
any two of R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H May be joined or fused to form a ring; and is provided with
Any two of R, R', R 1 、R 2 、R 3 、R 4 、R 5 、R A 、R B 、R C 、R D 、R E 、R F 、R G And R H May be joined or fused to form a ring, with the proviso that the group R * Is not adamantyl.
CN202211124031.9A 2021-09-17 2022-09-15 Organic electroluminescent material and device Pending CN115819463A (en)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US17/477,809 2021-09-17
US17/477,809 US20220112232A1 (en) 2020-10-02 2021-09-17 Organic electroluminescent materials and devices
US17/482,695 2021-09-23
US17/482,695 US20220115607A1 (en) 2020-10-02 2021-09-23 Organic electroluminescent materials and devices
US202163295235P 2021-12-30 2021-12-30
US63/295,235 2021-12-30
US17/584,471 US20220162246A1 (en) 2020-10-02 2022-01-26 Organic electroluminescent materials and devices
US17/584,471 2022-01-26
US17/842,117 2022-06-16
US17/842,117 US20230115552A1 (en) 2020-10-02 2022-06-16 Organic electroluminescent materials and devices
US17/899,649 2022-08-31
US17/899,649 US20230065887A1 (en) 2020-10-02 2022-08-31 Organic electroluminescent materials and devices

Publications (1)

Publication Number Publication Date
CN115819463A true CN115819463A (en) 2023-03-21

Family

ID=85523637

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211124031.9A Pending CN115819463A (en) 2021-09-17 2022-09-15 Organic electroluminescent material and device

Country Status (2)

Country Link
KR (1) KR20230041627A (en)
CN (1) CN115819463A (en)

Also Published As

Publication number Publication date
KR20230041627A (en) 2023-03-24

Similar Documents

Publication Publication Date Title
CN114512625A (en) Organic electroluminescent material and device
CN114975810A (en) Organic electroluminescent material and device
CN115073527A (en) Organic electroluminescent material and device
CN115215908A (en) Organic electroluminescent material and device
CN115073528A (en) Organic electroluminescent material and device
CN114835757A (en) Organic electroluminescent material and device
CN114230614A (en) Organic electroluminescent material and device
CN116903667A (en) Organic electroluminescent material and device
KR20230091823A (en) Organic electroluminescent materials and devices
KR20230021627A (en) Organic electroluminescent materials and devices
KR20220168558A (en) Organic electroluminescent materials and devices
CN115385963A (en) Organic electroluminescent material and device
CN115232172A (en) Organic electroluminescent material and device
CN115109098A (en) Organic electroluminescent material and device
CN115304645A (en) Organic electroluminescent material and device
KR20220128311A (en) Organic electroluminescent materials and devices
CN114478483A (en) Organic electroluminescent material and device
CN113292579A (en) Organic electroluminescent material and device
CN113185556A (en) Organic electroluminescent material and device
CN113072587A (en) Organic electroluminescent material and device
CN115819463A (en) Organic electroluminescent material and device
CN115043859A (en) Organic electroluminescent material and device
KR20230148772A (en) Organic electroluminescent materials and devices
CN115536707A (en) Organic electroluminescent material and device
CN114989197A (en) Organic electroluminescent material and device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination